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SUMMARY
1 Effects of native (LDL) and oxidised (ox-LDL) low
density lipoproteins on cholesterol uptake have been 
investigated in vitro, by examination of the effects 
of exposure to LDL and ox-LDL on the cholesterol 
content of rat aortic vascular smooth muscle (VSM) 
cells. Hypertension and hypercholesterolemia were 
also examined as coexisting and interactive risk 
factors by comparison of effects in WKY and SHRSP 
VSM cells.
2 On exposure of SHRSP and WKY VSM cells to 2 0(ig/ml
LDL and ox-LDL, small increases in free membrane 
cholesterol content were observed. Incubation of 
SHRSP VSM cells with LDL and ox-LDL produced greater 
increases in free cholesterol content compared to 
the WKY normotensive reference strain.
3 Effects of the antioxidants vitamin E and
N-acetyl-L-cysteine (NAC) , on LDL and ox-LDL 
mediated cholesterol uptake were examined in WKY and 
SHRSP VSM cells. In the presence of vitamin E both 
LDL and ox-LDL mediated effects were significantly 
attenuated in both cell types. Vitamin E also 
reduced basal free membrane cholesterol levels in a
concentration-dependent manner, suggesting effects 
in addition to antioxidant properties. NAC produced 
only a small attenuation of LDL and ox-LDL mediated 
effects on cholesterol uptake in WKY and SHRSP VSM 
cells, and did not alter basal free cholesterol 
content.
4 The effects of cell stretch on ox-LDL induced
cholesterol uptake were also examined in WKY VSM 
cells using a novel cell stretch apparatus. Results 
from this preliminary study were inconclusive, 
but demonstrated a potential model for future
investigations of hemodynamic forces on cellular 
function.
5 Effects of LDL and ox-LDL on vascular reactivity
were characterised in vitro, in the rat aorta. Rings 
of rat aorta were incubated in either vehicle, LDL, 
or ox-LDL for 5 hours before examination of vascular 
reactivity using a classical organ bath setup. 
Exposure to LDL and ox-LDL caused an impairment of 
carbachol-induced endothelium dependent relaxation 
and L-NAME induced contraction. Ox-LDL also impaired 
SNP-induced endothelium independent relaxation. LDL 
and ox-LDL exposure augmented phenylephrine-induced 
contraction and showed a tendency to increase
potassium chloride induced contraction, although the
higher concentration of LDL (500jig/ml) , caused 
attenuation of phenylephrine contraction and had no 
effect on potassium chloride induced contraction.
6 Possible mechanisms underlying LDL and ox-LDL
effects on vascular ractivity in the rat aorta were 
examined.
7 In tissues not incubated with LDL/ox-LDL, removal
of endothelium from the rings caused a significant 
reduction in L-NAME induced contraction by greater 
than 70%, demonstrating that nitric oxide assessed 
was mainly endothelium derived. Five hour
incubation resulted in only a small induction of 
the L-NAME response, which was blocked in the presence 
of dexamethasone. Removal of the endothelium prior 
to incubation, caused a considerable increase in the 
level of induction observed. This increase was 
inhibited by dexamethasone.
8 The effect of LDL and ox-LDL on iNOS and eNOS
activity was investigated by examination of the 
effects of dexamethasone on the L-NAME response+/-LDL 
and ox-LDL. Incubation with both LDL and
dexamethasone reduced L-NAME induced contraction to 
a similar degree as incubation with dexamethasone 
alone. Ox-LDL treated tissues showed a similar 
pattern, with a trend towards lower responses when 
incubation included both ox-LDL and dexamethasone.
9 Effects of vitamin E on LDL-induced alterations of
vascular reactivity were examined. Vitamin E had no 
significant effect on LDL-induced alterations of 
vascular reactivity. Results suggested that only 
LDL-mediated attenuation of maximum carbachol 
induced relaxation may be altered in the presence of 
vitamin E (although this did not reach statistical 
significance).
10 Effects of superoxide dismutase (SOD) on LDL and
ox-LDL induced alterations of vascular reactivity 
were examined. SOD alone, showed a tendency to 
reduce maximum phenylephrine induced contraction 
when compared with appropriate controls. Incubation 
in the presence of SOD did not significantly alter 
LDL and ox-LDL induced effects on vascular 
reactivity.
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1
GENERAL INTRODUCTION
1
1.1 ATHEROSCLEROSIS
Atherosclerosis is a condition involving arterial 
damage which plays an important role in the 
pathogenesis of numerous disease states affecting 
the coronary, cerebral, and peripheral vascular 
systems. Clinical consequences include ischaemic 
heart disease, myocardial and cerebral infarction, 
gangrene, and loss of function of the extremeties 
(Feher and Richmond, 1991; Ross, 1993).
Atherosclerosis has become of increasing concern in 
the later half of this century due to its escalating 
role in clinical disease, to the extent that it is 
now responsible for up to 75% of all deaths in 
western society.
Aortic fatty streaks are found in many children 
under three years, in almost all persons by the age 
of ten, and in approximately 90% of all individuals 
over thirty regardless of race, geography, or gender 
(Callow, 1991).
It has been concluded that atherosclerosis develops 
as a result of multiple complex interactions, and 
that such events involve both environmental and 
genetic factors.
2
Most of those clinically affected have several 
unfavourable associations, including a history of 
cigarette smoking, high blood pressure, and elevated 
levels of blood cholesterol. Of these associations 
elevated cholesterol levels appear prominent 
(Walton, 1975; The Pooling Project Research Group, 
1978; Kannel and Sytkowski, 1987; Feher and 
Richmond, 1991).
1.2 CHOLESTEROL - AN IMPORTANT RISK FACTOR
Hypercholesterolaemia is well established as a major 
risk factor for atherosclerosis. This has been
substantiated by numerous experimental and clinical 
investigations which show a concentration-related 
increase in the risk of atherosclerotic
complications when plasma cholesterol levels exceed 
4.1-4.7mmol/l (160-180mg/dl)(Witzum, 1993).
Plasma lipids such as cholesterol and triglyceride 
are poorly soluble and are transported through the 
body bound to proteins. These water soluble
lipoproteins have become the focus of much interest 
in recent years.
Of the 6 known classes of lipoproteins low density 
lipoproteins (LDL) are of particular importance in 
the development of atherosclerotic disease. LDL' s
3
are the major cholesterol carrying particles in the 
blood (making up 60-70% of the total plasma 
cholesterol). Responsible for uptake and transport 
of cholesterol from ingested fats and from 
cholesterol producing cells in the body, LDL's 
deliver cholesterol to cells in the blood vessels 
and muscles.
High levels of this lipoprotein type are recognised 
as salient in the development of atherosclerotic 
disease (Feher and Richmond, 1991; O’Brien et al., 
1991).
1.2.1 THE 'CHOLESTEROL HYPOTHESIS'
Many studies initially focused on the 
pathophysiological events involved in
atherosclerosis such as intimal foam cell formation 
and development of the 'fatty streak'.
Discovery of the LDL receptor led to the logical 
assumption that this was the lipid uptake mechanism 
for macrophages, the cell type chiefly accounting 
for cholesterol laden 'foam cells' seen in the early 
stages of atherosclerosis.
The LDL receptor was to become a principal part of 
the original 'cholesterol hypothesis'.
4
1.2.2 THE ’MODIFIED LIPOPROTEIN HYPOTHESIS'
Subsequent studies however, showed that on 
incubation of cells with LDL, the rate at which 
native LDL uptake occurred was not sufficient to 
generate foam cell formation.
In 1979, Goldstein et al., discovered that 
acetylation of LDL lead to a massive increase in 
macrophage uptake by a receptor dependent mechanism 
(the receptor involved was later to be known as the 
scavenger or acetyl LDL receptor).
This lead to the suggestion that LDL modification 
must be required, and that it was some modified form 
of LDL that was the actual ligand taken up by 
monocytes/macrophages (Goldstein et al., 1979).
A number of chemical modifications were found to 
rapidly increase LDL uptake and accumulation 
(Goldstein et al., 1979; Mahley et al., 1979;
Fogelman et al., 1980; Henriksen et al., 1981;
Steinberg et al., 1989), however of these, oxidation
was found to have the strongest biological 
feasibility.
5
Such oxidative modification has been demonstrated in 
vitro by endothelial cells (Henriksen et al., 1981;
Steinbrecher et al., 1984), vascular smooth muscle 
cells (Morel et al., 1984), and
monocytes/macrophages (Cathcart et al., 1985; 
Hiramatsu et al., 1987); the 3 major cell types of 
the arterial lesion.
This oxidative modification has also been 
demonstrated in vivo by groups such as Yla-Herttuala 
et al., 1989. Studies of the physical and chemical 
properties of LDL from atherosclerotic lesions of 
rabbit and man have provided strong evidence for the 
presence and oxidative modification of LDL within 
these focal areas.
Exact mechanisms by which LDL is oxidatively 
modified are not, however, fully understood.
1.2.3 HYPERTENSION AS AN INTERACTIVE RISK FACTOR
As well as showing the multifactorial origin of 
atherosclerosis, epidemiological studies have made 
it clear that identifiable risk factors may act 
independently, or may reinforce one another when 
they coexist (sometimes synergistically)(Walton, 
1975; Feher and Richmond, 1991).
6
Hypertension is one of the most prevalent and most 
potent determinants of atherosclerotic
cardiovascular disease. In particular, hypertension 
is a well known risk factor when associated with 
elevated cholesterol levels (Hollander et al., 1976; 
Chobanian, 1983; McGill et al., 1985; Kannel and
Sytkowski, 1987; Chobanian et al., 1989).
Recently, Galle et al., 1994, found that dose 
dependent infiltration of lipoprotein into the
vessel wall and the accompanying attenuation of 
acetylcholine-induced dilations, only occurred under 
high pressure conditions.
This is similar to the findings of Curmi et al. , 
1990, who showed a marked increase in LDL uptake 
with increasing transmural pressure.
Such studies have led to the suggestion that LDL 
uptake leading to atherosclerotic disease is 
dependent not only on oxidative modification, but 
also on transmural pressure.
A fuller understanding of such interactive 
mechanisms may be of importance to patients with 
both hypercholesterolemia and hypertension.
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1.3 ATHEROGENIC EFFECTS OF LDL CHOLESTEROL
Since the formation of the 'modified lipoprotein 
hypothesis' numerous potentially atherogenic
mechanisms have been ascribed to oxidised LDL 
(ox-LDL) including:-
1 Enhanced uptake by macrophages
2 Chemotactic attraction of circulating monocytes
3 Inhibition of motility of tissue macrophages
4 Cytotoxicity
5 Altered gene expression
6 Immunogenic effects
7 Adverse alteration of coagulation pathways
8 Adverse alteration of vascular reactivity 
(Witzum and Steinberg, 1991).
The association of ox-LDL with various biological 
effects has however proved controversial, with 
conflicting results between different laboratories. 
Such discordance of results may be explained by the 
different preparation techniques used in 
laboratories.
Ox-LDL is not a single homogeneous entity, and 
differences may occur as a result of the cell type 
or exact metal ion concentration used to oxidise the
LDL, the time of incubation, the presence of 
differing amounts of endogenous antioxidants in the 
LDL particles, differences in the fatty acid 
composition, or other properties such as size or 
density of the LDL (Rosenfeld, 1991; Witztum and 
Steinberg, 1991).
Additionally considerable variability may occur from 
preparation to preparation even when every effort is 
made to hold conditions constant.
The vast majority of early studies investigating the 
role of oxidised lipoproteins in atherosclerotic 
progression focused on pathphysiological events such 
as scavenger receptor uptake and foam cell 
formation.
It is only relatively recently that emphasis has 
been placed on effects of oxidised lipoproteins, in 
particular their effect on the cellular functions 
associated with the regulation of vascular tone.
1.4 THE ENDOTHELIUM
The vascular endothelium is a dynamic participant in 
circulatory homeostasis due to its numerous 
physiological roles including the regulation of:-
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1 Haemostasis and Thrombosis - via antiplatelet, 
anticoagulant, and fibrinolytic effects
2 Vascular Remodeling - via the production of growth 
promoting and inhibiting substances
3 Permeation - via the control of exchange, and 
active transport, of substances across the artery 
wall
(Ross, 1993; Daugherty et al., 1995).
Importantly, the endothelium has also been shown to 
play a crucial role in the maintenance of vascular 
tone via the production and release of 
vasocontractile and vasorelaxant factors.
Known contractile factors include endothelin, 
angiotenisn II, and the cyclooxygenase pathway 
products thromboxane prostaglandin H2, and
superoxide, whereas relaxant factors identified to 
date include prostacyclin and nitric oxide (NO) 
(Luscher, 1993; Ross, 1993; Daugherty et al., 1995).
Of these factors NO has proved of particular 
importance, having a definitive role in the normal 
control of basal tone.
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1.5 NITRIC OXIDE
In 1980, Furchgott and Zawadzki first described a 
paracrine vascular hormone with potent vasodilatory 
activity, that was subsequently termed endothelium 
derived relaxing factor (EDRF), and is now known to 
be identical or similar to NO.
NO has since been implicated in a wide range of 
physiologic roles in the vasculature including
1 Preservation of endothelial permeability and 
integrity
2 Regulation of vascular smooth muscle proliferation
3 Regulation of vascular tone
4 Regulation of leucocyte-vessel wall interactions
5 Provision of antithrombic activity 
(Welch et al., 1995).
In particular NO is a primary determinant of resting 
vascular tone through continuous basal release, and 
causes vasodilation in response to various 
vasodilator agents such as acetylcholine, 
bradykinin, substance P, and increases in flow and 
shear stress (Calver et al., 1993).
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1.5.1 THE NITRIC OXIDE PATHWAY
Endothelium-dependent vasodilation, and basal
vascular tone, are mediated via the synthesis, 
release, and effect of NO (Fig. 1.1).
NO is formed from L-arginine via the constitutive 
endothelial form of nitric oxide synthase (eNOS), 
and causes relaxation via activation of guanylyl 
cyclase in the vascular smooth muscle (Luscher et 
al., 1995).
Inhibition of this NO synthesis can be acheived on 
exposure to nitric oxide synthase inhibitors such as 
L-NAME, or by removal of the endothelium.
Interestingly an inducible form of nitric oxide
synthase (iNOS) also exists and has been found in 
various cell types including macrophages and smooth 
muscle cells (Welch et al., 1995).
iNOS transcription may be activated by a range of
substances including bacterial lipopolysaccharide
(endotoxin), and various cytokines.
It is now thought that dysregulation of the NO 
pathway may contribute to the pathogenesis of a
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The Nitric Oxide Pathway
PLATELETS
cGMP
Shear Stress Agonist
L-NAME
L-Arginine
ENDOTHELIUM
NO
sGCi
cGMP
i
RELAXATION
iNOS
-► sGCa
VASCULAR SMOOTH 
MUSCLE CELL
Fig. 1.1 - The nitric oxide pathway - the endothelium
produces nitric oxide which causes relaxation.
eNOS = endothelial/constitutive nitric oxide synthase; iNOS = 
inducible nitric oxide synthase; sGCi/a = inactive/active 
soluble guanylyl cyclase; GTP = guanosine triphosphate, cGMP = 
cyclic guanosine monophosphate; L-NAME = L-nitro-arginine 
methylester.
(Luscher et al., 1995)
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number of vascular disorders including hypertension, 
reperfusion injury, and atherosclerosis.
1.6 EFFECTS OF LDL CHOLESTEROL ON THE REGULATION OF 
VASCULAR TONE
Alterations in vascular function are well documented 
in the development of atherosclerotic disease 
(Heistad et al., 1984; Berkenboom et al., 1987; 
Shimokawa and Vanhoutte, 1988; Casino et al., 1995) . 
Risk factors such as elevated cholesterol levels 
have been linked to these alterations, however exact 
mechanisms are not fully understood.
As a result of the proliferation of studies 
investigating the effects of LDL cholesterol on 
vascular tone, it has become apparent that LDL 
exerts 2 main effects
1 LDL profoundly affects the endothelium-dependent 
relaxation of isolated blood vessels
2 LDL a ffects the responsiveness of vascular smooth 
muscle cells to vasoconstrictor stimuli
These vascular effects have been shown to be 
primarily due to the oxidised form of LDL (although 
effects have been observed to a lesser extent on
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exposure of tissues to native LDL - Andrews et al., 
1987; Jacobs et al., 1990; Galle et al., 1991; Myers 
et al., 1994).
1.6.1 EFFECTS OF LDL CHOLESTEROL ON 
ENDOTHELIUM-DEPENDENT RELAXATION
Atherosclerosis in animals and humans is associated 
with markedly reduced endothelium-dependent 
relaxation, and this attenuated responsiveness is 
thought to play an important role in associated 
disease states (Berkenboom et al., 1987; Bossaller 
et al., 1987; Forstermann et al., 1988; Shimokawa
and Vanhoutte, 1988).
Knowledge of this impairment of
endothelium-dependent vasodilation has led to a 
focus of interest on the possible link between 
lipoproteins and impaired synthesis/effect of NO.
An increasing body of evidence has now accumulated 
to suggest that ox-LDL contributes significantly to 
this altered vasomotor responsiveness.
Ox-LDL-induced impairment of NO-dependent relaxation 
has been shown in various animal models including 
porcine coronary artery (Simon et al.,1990; Tanner
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et al., 1991), and rabbit aorta (Jacobs et al.,
1990; Kugiyama et al., 1990).
Studies in human and animal hypercholesterolaemic 
models have shown impaired NO-dependent 
vasorelaxation to a variety of substances including 
acetylcholine, substance P, histamine, and thrombin 
(Shimokawa and Vanhoutte, 1988; Flavahan , 1992;
Casino et al., 1995).
Although impaired NO function is known to take place 
the mechanisms by which this dysfunction occurs 
remain controversial.
1.6.1.1 Nitric Oxide Synthase Inhibition
In recent years a limited number of studies have 
suggested that low-density lipoproteins affect 
vascular reactivity by inhibiting the enzyme nitric 
oxide synthase (NOS).
In 1995 Liao et al., found that ox-LDL decreased the 
expression of endothelial NOS (eNOS) in human 
saphenous vein endothelial cells. This was thought 
to be through a combination of early transcriptional 
inhibition and post-transcriptional mRNA
destabilisation.
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Yang et al., 1994, found that inducible NOS (iNOS)
could also be inhibited by ox-LDL, on examination of 
iNOS activity in an activated macrophage cell line.
Such results indicate a potential mechanism for 
LDL/ox-LDL induced NO dysfunction via alteration of 
NOS activity.
1.6.1.2 Alteration of Membrane Physicochemical 
Structure and Calcium Influx
Various groups have suggested that the inhibitory 
effect of ox-LDL is due to lysophosphatidylcholine, 
which is generated in LDL during oxidation and 
transferred directly into the plasma membrane of 
endothelial cells.
Once integrated into the membrane
lysophosphatidylcholine is thought to affect the 
functioning of membrane receptors specific for 
numerous vasodilator agonists (Kugiyama et al., 
1990; Yokoyama et al., 1990; Murohara et al., 1994).
Indeed, increased cholesterol content within the 
cell membrane has been suggested as an initiator of 
proatherogenic changes at the level of membrane 
physicochemical structure and calcium influx 
(Scott-Burden et al., 1989; Yeagle, 1989; Bialecki
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et al., 1991; Figueiredo et a l., 1991; Thorin et
al., 1995).
Changes observed following cholesterol exposure 
range from alterations in Na-H antiporter activity 
and intracellular calcium, to activation of 
phosphatidylinositol metabolism and induction of 
growth-related metabolism.
Deposition of lipids in atherosclerotic lesions 
suggests that the accumulation of cholesterol in 
cell membranes may be one of the earliest 
biochemical changes in the progression of the 
disease.
Since changes in membrane-bound cholesterol are 
known to alter the fluidity and permeability of 
lipid membranes, and the activation of excitable 
cells critically depends on the functional 
characteristics of this surface membrane, it seems 
possible that cholesterol-induced changes in the 
membrane function may be responsible for the altered 
vasoactivity observed.
Studies by Tanner et al., 1991, suggest that the
inhibitory effects of ox-LDL are derived from its 
ability to 'interfere with the receptor-operated
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release of L-arginine from intracellular stores or 
the synthesis of the amino acid’ (L-arginine being 
the precursor for NO) .|( Tanner et al. however, 
further suggest that the inhibitory effects of 
ox-LDL are not mimicked by addition of 
lysophosphatidylcholine to their coronary artery 
system ) •
Data by Jeserich et al., 1992, also support this
theory with studies showing an approximately 30% 
reduction of plasma L-arginine levels in patients 
with hypercholesterolemia.
Flavahan, 1992, has taken this theory further having 
observed complex selective dysfunction of 
agonist-induced relaxation in a number of different 
arterial preparations. This has led him to suggest 
that endothelial dysfunction occurs in 2 distinct 
phases (Fig. 1.2):—
1 Early in the disease process or after low 
concentrations of ox-LDL, endothelial dysfunction 
may be caused by a selective impairment in certain G 
proteins or G protein-dependent signal transduction 
pathways (in particular that of the pertussis 
toxin-sensitive GL protein).
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2 As the disease progresses or as the concentration 
of ox-LDL is increased, the dysfunction may spread 
to other signal transduction processes, causing 
inhibition by a non-specific action.
(Flavahan, 1992).
In endothelial cells this wider spread dysfunction 
may be due to inhibition of NO synthesis and release 
(eg. by decreased availability of L-arginine or NOS 
inhibition), and in the vascular smooth muscle by 
attenuation of NO effect (eg. decreased sensitivity 
to NO or increased NO breakdown following release).
1.6.1.3 Free Radical Neutralisation
Finally, a 3rd alternative theory accumulating 
considerable interest is that of ’free radical 
neutralisation'.
Recent observations of Galle et al. , 1991, suggest 
that both native and oxidised LDL inhibit 
endothelium-dependent vasodilation by inactivating 
NO released from endothelial cells. Galle et al., 
have further theorised that inactivation may be due 
to the hydrophobic core of the lipoproteins acting 
as a ’sink' for NO.
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Proposed mechanisms of Endothelial Dysfunction Associated 
with Atherosclerosis and Ox-LDL
Serotonin
Bradykinin ADP, ATP
UK14,304
Gi
AC, K+Ch? PLC?
ENDOTHELIAL
CELL
Atherosclerosis (EARLY)
LOW (ox-LDL) Q
Atherosclerosis (LATE)
HIGH (ox-LDL) Q
NO
Fig. 1.2 - Proposed mechanisms of endothelial dysfunction
associated with atherosclerosis and ox-LDL.
AC = adenyl cyclase, K+Ch = potassium channels, PLC = 
phospholipase C; NO = nitric oxide.
(Flavahan, 1992)
21
Further evidence to support this theory include the 
results of Jacobs et al., 1990, who discovered that 
both LDL and ox-LDL reversibly inhibited relaxations 
evoked by exogenous NO in the rabbit aorta. Ox-LDL 
(but not LDL), also reversibly inhibited relaxations 
evoked by the NO donor compound glyceryl trinitrate.
Advancement of this theory has resulted in the 
development of the ’Free Radical Hypothesis’ in 
which NO is thought to be inactivated by free 
radical neutralisation.
Araujo et al., 1995, found that reactive oxygen
species production by leucocytes was positively 
correlated with elevated VLDL or LDL levels in 
clinical studies.
Also strengthening this theory were the discoveries 
of Ohara et al., 1995, who found that dietary 
correction of hypercholesterolaemia improved 
endothelium-dependent vascular relaxation but also 
normalised endothelial superoxide anion production 
(increased in the hypercholesterolaemic state).
Such results therefore indicate a potential 
mechanism for LDL/ox-LDL induced NO dysfunction, via
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inactivation of the NO molecule by free radical 
neutralisation.
1.6.2 EFFECTS OF LDL CHOLESTEROL ON VASCULAR 
SENSITIVITY TO VASOCONTRACTILE STIMULI
Many studies have also examined the effect of LDL 
cholesterol on vascular responses to vasocontractile 
stimuli.
Results indicate that cholesterol potentiates 
vascular smooth muscle reactivity to several 
vasoconstrictor substances including norepinephrine 
and serotonin; and have shown that LDL may also 
elicite contractile responses itself (Bloom et al., 
1975; Yokoyama et al., 1979; Rosendorff et al.,
1980; Heistad et al., 1984; Broderick et al., 1989; 
Galle et al., 1990; Simon et al., 1990).
Studies in vitro have suggested several mechanisms 
by which these contractile responses may be 
augmented.
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1.6.2.1 Alteration of Membrane Physicochemical 
Structure and Calcium Influx
As previously mentioned, increased cholesterol 
content within the cell membrane is thought to be an 
initiator of proatherogenic changes at the level of 
membrane physicochemical chemical structure and 
calcium influx (Scott-Burden et al., 1989; Yeagle, 
1989; Bialecki et al., 1991; Figeiredo et al., 1991; 
Thorin et al., 1995).
Yokoyama and Henry, 197 9, found that in the presence 
of verapamil (an agent that acts primarily by 
inhibiting the inward movement of calcium into the 
cell), there was a potent inhibition of 
cholesterol-induced contractions.
Similarly, Galle et al., 1990, found that 
preincubation with the calcium antagonists 
verapamil, diltiazem, and nitrendipine inhibited 
vasoconstrictions evoked by ox-LDL in the presence 
and in the absence of a contractile agonist.
Such results have led to the suggestion that 
increased cholesterol content of membranes may 
enhance cation permeability and therefore alter 
vascular responses to calcium and potassium.
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1.6.2.2 Indirect Alteration as a Result of NO 
Dysfunction
More recently it has been suggested that impairment 
of NO synthesis/effect may be responsible for the 
augmented vasoconstrictor responses observed.
It is thought that due to NO dysfunction natural 
counterbalance mechanisms are depressed and 
vasoconstrictor responses go unchecked.
It therefore seems likely that ox-LDL-induced 
alteration of vascular reactivity will be found to 
occur as a result of a complex multidysfunctional 
mechanism, and that both impairment of 
endothelium-dependent relaxation and augmentation of 
contractile responses develop as a result of 
multiple dysfunctional sites.
Mechanisms by which oxidised LDL alter vasoactivity 
remain controversial. An increased knowledge of 
these mechanisms, and the complex interactions 
between the various atherogenic factors and 
dysfunctional sites will improve understanding of 
the physiology and pathophysiology of the vascular 
system. This in turn will provide a new outlook for 
the treatment of atherosclerosis and associated 
disease states.
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1.7 ANTIOXIDANT PROTECTION
The formation of the 'modified lipoprotein
hypothesis' (and more recently the suggestion that 
ox-LDL may exert its effect via a free radical 
induced dysfunctional site), has stimulated 
considerable interest in the possibility of 
administration of antioxidants to protect and 
prevent against LDL-mediated atherosclerotic 
disease.
Since the mid 1980's there has been an explosion in 
the number of studies investigating antioxidant 
protection, in particular against cardiac and
circulatory disease.
Antioxidants studied include chemical antioxidants 
such as N,N'-diphenyl-phenylenediamine (DPPD), 
probucol (and structurally related compounds such as 
butylated hydroxytoluene (BHT)), and natural dietary 
antioxidants such as the vitamins A, C, and E, 
carotenoids (in particular beta-carotene) , and the
trace mineral selenium.
Numerous studies have been carried out examining the 
effectiveness of these various antioxidants, in 
reducing LDL oxidation, and protecting against
26
cardiovascular disease. Results have, however proved 
controversial.
P-carotene, vitamin C, and vitamin E have been shown 
to reduce the degree of LDL oxidation in clinical 
trials (Jialal and Grundy, 1993; Gilligan et al., 
1994; Fuller et al., 1996), and evidence suggests 
that the presence of these antioxidant vitamins in 
the blood may have a protective role against 
cardiovascular disease (reviewed by Rice-Evans, 
1995; Levine et al., 1996; Stephens et al., 1996).
Gilligan et al., 1994, however, found that although 
antioxidant administration reduced suceptibility of 
LDL to oxidation, impaired endothelial function in 
hypercholesterolemic patients remained unaltered.
Additionally, Kok et al., 1987, found no clear 
association between low serum selenium, vitamin A, 
and vitamin E levels and mortality from 
cardiovascular disease.
Further research is therefore required to clearly 
elucidate effects and associations of these 
antioxidants individually and in combination, and to
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establish their utility in the prevention of 
coronary artery disease.
1.8 AIMS
The aims of this thesis were as follows:-
1 To characterise the effects of LDL and ox-LDL on 
vascular reactivity in vitro.
2 To investigate the mechanisms underlying LDL and 
ox-LDL induced effects on vascular reactivity in 
vi tro.
3 To examine hypertension and hypercholesterolemia 
as coexisting risk factors in vitro, and elucidate 
combined effects on cholesterol uptake as a possible 
interactive mechanism.
4 To examine the effects, and possible benefits of 
antioxidants, in the prevention of LDL and ox-LDL 
induced vascular dysfunction.
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MATERIALS AND METHODS
2.1 Materials
See appendix 1.
2.2 METHODS
2.2.1 PREPARATION OF VASCULAR SMOOTH MUSCLE CELLS
Vascular smooth muscle cells were prepared via 
enzymatic dissociation as described by Devlin et 
al., 1995.
Male WKY and SHRSP rats were sacrificed by overdose 
of sodium pentobarbitone administered by 
intraperitoneal injection. The thoracic aorta was 
dissected under sterile conditions and immediately 
placed in ice cold serum free DMEM. Following 
dissection all work was carried out aseptically in a 
laminar flow tissue culture cabinet (class II) where 
possible. Excess fat and connective tissue was 
carefully removed, the clean artery placed in 2.5ml 
digest mix (see appendix 3), and incubated for 30 
minutes at 37°C, 5%C02/95% air.
Following digestion the artery was placed in serum 
free DMEM and the adventitia carefully removed. The 
vessel was then cut open longitudinally to expose 
the endothelial layer, and placed in 2.5ml. fresh 
digest mix for a further 30 minutes as previously.
30
The vessel was then cut into very small pieces 
(l-2mm in size) and placed in fresh digest mix. The 
tissue was incubated at 37°C, 5%C02/95% air for a
further 30 minutes or until a single cell suspension 
was obtained (NOTE- tissue was periodically 
titurated using a fine-tipped pastette during this 
time) .
Once a sufficient yield of cells had been obtained, 
(as judged by observation under a microscope) 2mls 
ice cold VSM growth medium (see appendix 4) was 
added, the suspension dispersed using a fine tipped 
pasteur pipette, and centrifuged in a Sorvall RT600B 
refrigerated centrifuge at 900rpm (120g) for 10 
minutes at 4°C. The digest mix was poured off and 
5mls of fresh VSM growth medium added. The solution 
was dispersed for a final time and the VSM cells (1 
x 104cells/ml) seeded into a 25cm2 cell culture 
flask, which was incubated at 37°C in 5%C02/95%air 
overnight.
The following day cells were checked to ensure 
attachment had occured. The VSM growth medium was 
removed, the cells washed with 5mls PBS, 5mls of 
fresh growth medium added, and the cells reincubated 
at 37°C, 5%C02/95%air.
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Medium was changed every 2 days until cells were 
confluent, at which time cells were subcultured into 
a 260cm2 flask from which a cell line was 
established.
2.2.2 MAINTENANCE OF CELLS
2.2.2.1 Cell Culture
All cell culture procedures were carried out in a 
laminar flow tissue culture cabinet (class II) using 
sterile medium, buffers, and equipment unless 
otherwise stated.
2.2.2.2 Cell Passage
On reaching confluence, cells were passaged into 
flasks as per standard procedure using trypsin EDTA. 
Subculture and harvesting of cells was carried out 
by washing the cells briefly in a calcium and 
magnesium free balanced salt solution/PBS and 
detaching the cells with 0.05% trypsin in 0.02% EDTA 
(V:V) .
For experimentation, cells were passed into 6-well 
multiwell culture plates (2ml/well) at a plating 
density of 0. lxl06cells/ml growth medium (NOTE- for 
cell stretch experiments see 2.2.5).
Cells were only used for experimentation prior to 
their 12th subculture.
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2.2.2. 3 Changing of Medium
Medium in flasks was removed and replaced with fresh 
solution every 2 days (medium in 6-well multiwell 
culture plates (2ml/well), and cell stretch 
apparatus changed every day).
2.2.3 LDL/OX-LDL PREPARATION
30mls of whole blood was collected into tubes 
containing EDTA (lmg/ml), and centrifuged in a 
Sorvall RT600B refrigerated centrifuge at 3,000rpm 
(l,250g) for 10 minutes, at 4°C.
The plasma/top layer was removed and 4ml volumes 
aliquoted into Sorvall 93237 ultracentrifuge tubes. 
0.32mls of 1.182g/ml density solution (see appendix 
2) was added to each tube and tubes mixed with a 
pasteur pipette. 2mls of 1.019g/ml density solution 
was overlayed and the plasma samples 
ultracentrifuged at 47,000rpm (150,000g), at 4°C
overnight.
The top 2mls of each ultracentrifuge sample was 
removed and discarded. 1.47mls of 1.182g/ml density 
solution was added to the remaining solution, and 
tubes mixed with a pasteur pipette. 0.53mls of 
1.063g/ml density solution was slowly overlayed, and 
the ultracentrifugation repeated.
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The top l-2mls (yellow layer) was removed from each 
tube and the protein value estimated by reading 1ml 
of solution in a quartz cuvette at 280nm against
distilled water (dH20) ie. 0.230 = 230|ig/ml. The LDL 
solution was then diluted to a protein concentration 
of approx. 200|ng/inl using 1/10 dialysis buffer (NOTE 
- for organ bath experiments LDL solution was not 
diluted at this stage, as required at high 
concentrations).
The LDL solution was dialysed in 0.01M phosphate 
buffer containing 0.015M NaCl, pH7.4 (ie. 2 litres 
1/10 dialysis buffer). Dialysis was carried out in 
the dark at 4°C for 40 hours. Four changes of buffer 
were made during this time.
Following dialysis protein content was measured as 
previously and solutions diluted using 1/10 dialysis 
buffer if required.
The solution was split into 2 equal amounts and 
treated as follows
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LDL CHOLESTEROL SOLUTION
Dialysed LDL solution was poured into tubes 
containing EDTA (lmg/ml) to protect against 
oxidation, and stored in the dark at 4°C until 
required.
OX-LDL CHOLESTEROL SOLUTION
20|j,ls of copper chloride solution was added per 
millilitre of dialysed LDL solution to aid 
oxidation, and the solution left at room temperature 
for approx. 8 hours. Following oxidation the 
solution was stored in the dark at 4°C until 
required.
LDL and ox-LDL solutions were kept for a maximum of
4 weeks.
2.2.4 CHOLESTEROL UPTAKE IN CULTURED VASCULAR SMOOTH 
MUSCLE CELLS FROM SHRSP AND WKY RATS
Cells were grown in 6-well multiwell culture plates 
(2ml/well). On reaching confluence cells were 
incubated at 37°C, 5%C02/95% air, overnight as
follows:-
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Incubation for Cholesterol Uptake Experiments
Plate No. 1 1 1
Incubation
Medium
Medium 199 
+
control 
volume PBS
Medium 199 
+
20|ig/ml LDL
Medium 199 
+
20|ig/ml
ox-LDL
+/- Vit. E 
NALC
+/- Vit. E 
NALC
+/- Vit. E 
NALC
Final Volume 2ml 2ml 2ml
TABLE 2.1 - Incubation set up for 'cholesterol uptake1
experiments in cultured WKY and SHRSP vascular smooth muscle 
cells
Following incubation plates were washed twice with 
2mls PBS buffer (pH7.4). Cells were scraped from
wells into 250fils of buffer, and transfered into 1ml 
eppendorf tubes (2 wells/500fils per eppendorf) .
Cholesterol was extracted and free and total 
cholesterol determined using the method described by
Gamble et al., 1978. 500(ils of chloroform:methanol
(2:1) was added to each tube, the samples vortex 
mixed, and left to extract overnight at 4°C.
The tubes were then centrifuged at 13,000rpm
(9, 000g) for 15 minutes. The bottom layer (275|ils 
chloroform) was removed into polypropylene
36
Fl
u
or
es
ce
n
ce
Cho lesterol  Assay Standard  Curve
n=10
250
200
150
50
0
3.52.5 3.00.0 0.5 1.0 1.5 2.0
Cholestero l  (pg)
Example of standard curve for cholesterol assay. In general, 
samples fell on lower half of the curve.
test-tubes and the supernatant stored for protein 
analysis at a future date. The chloroform was 
evaporated at 37°C under a stream of air, following
which 250jils of 95% ethanol was added, and the tubes 
vortex mixed thoroughly. Samples were bath sonicated 
on ice for 15 minutes to dissolve the cholesterol.
Assay solutions were prepared as follows
Stock solution Free Cholesterol Total Cholesterol
K2HP04 buffer 20ml 16ml
Cholesterol esterase 0ml 4ml
Cholesterol oxidase 4ml 4ml
Peroxidase 4ml 4ml
Triton X 100 2ml 2ml
Na cholate 2ml 2ml
p-OH-phenylacetic acid 6ml 6ml
NOTE - Glass tubes used for assay
(see appendix 5)
The cholesterol standard stock solution was diluted 
1 in 10 and a standard curve prepared. The points on 
the standard curve were 0, 0.4, 0.8, 1.2, 1.6, 2.0,
2.4, 2.8, and 3.2 |ig cholesterol content.
lOOpls of each standard and sample was added to both 
free and total cholesterol assay tubes (note
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standards were assayed in duplicate) . 1ml of the
assay reagent (free or total) was added to each
tube, and the tubes were vortex mixed.
TOTAL CHOLESTEROL
Total cholesterol samples were incubated for 15
minutes at 37°C in a shaking water bath. Following 
incubation samples were left for 15 minutes and 
fluorescence read at 325-415nm.
FREE CHOLESTEROL
Free cholesterol samples were incubated for 15
minutes at 37°C in a shaking water bath and left to 
sit for a minimum of 5 minutes before fluorescence 
was read (325-415nm).
Calculated values were multiplied by a factor of 2.5 
to give total sample values.
2.2.5 EFFECT OF CELL STRETCH ON CHOLESTEROL UPTAKE 
IN VASCULAR SMOOTH MUSCLE CELLS
Vascular smooth muscle cells were prepared as 
previously described.
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2.2.5.1 Preparation of Cell Stretch Apparatus
The perspex components of the cell stretch apparatus 
were sterilised overnight in 7 0% methanol and 
allowed to dry within a laminar flow hood.
PRETREATMENT OF SILICONE SHEETING
Silicone sheets were cut into rectangles 110 x 100mm 
in area, cleaned by washing in 0.1% Decon 75 
solution, and rinsed thoroughly in dH20. The silicone 
was then transferred to aluminium foil and 
autoclaved at 121°C.
Apparatus was assembled under sterile conditions 
within a laminar flow hood. Autoclaved silicone 
sheets were mounted on vertially aligned screws, the 
apparatus fully constructed, and sheeting stretched 
to a precalculated resting tension.
Following assembly lOmls of a 25|ig/ml fibronectin 
solution dissolved in serum-free medium was applied 
to the silicone and incubated at room temperature 
for 20 minutes. Silicone was rinsed with serum-free 
medium and allowed to dry at room temperature 
(Deehan, 1994) .
Cells were plated on the dried silicone at a density 
of 2.5 x 106 cells/ml and grown in a serum enriched
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medium (as per vascular smooth muscle growth medium 
- see appendix 3 - with 10% newborn calf serum in 
place of horse serum).
2.2.5.2 Cell Stretch Protocol
DAY 0 Construction of apparatus - cells passaged
and left to attach overnight 
DAY 1 Medium changed
DAY 2 Cells incubated in 20fig/ml ox-LDL in
medium 199 for 24 hours + /- 20% stretch 
DAY 3 Incubation terminated, wells scraped and
samples assayed as previously described
2.2.6 PROTEIN DETERMINATION - Cell Culture
Protein was measured by a method adapted from Lowry 
et al., 1951.
Protein samples were evaporated dry using a Cryovap 
centrifuge at 60°C for 3 hours. 250fils of 1M sodium 
hydroxide was added to each sample, the samples 
vortex mixed, and left for 48 hours at 4°C.
A standard curve was prepared using bovine serum 
albumin (BSA) as the protein standard. Points on the 
standard curve were 0, 2.5, 5, 10, 20, 40, 50, 60,
70, 80, and 90fig/2 00|Lils.
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2 0 0|j,l s of each sample (neat + 1/10 dilution) and
standard (in duplicate) were added to assay tubes. 
1.5mls of sodium copper tartrate reagent (see 
appendix 6) was added to each tube, and the tubes 
vortex mixed.
After 10 minutes 150|ils of Folins phenol reagent was 
added to each tube. The tubes were vortex mixed and 
incubated at room temperature for 30 minutes.
Samples were centrifuged in a Sorvall RT600B 
refrigerated centrifuge at 3,000rpm (l,250g) for 5
minutes, at 4°C. Protein measurements were read using 
a spectrophotometer at a wavelength of 750nm.
Calculated values were multiplied by a factor of 1.25 
to give total protein content of samples.
2.2.7 EFFECT OF CHOLESTEROL ON VASCULAR RESPONSES
Male Sprague Dawley rats (>6 weeks) were sacrificed 
by exposure to an overdose of halothane. The 
thoracic aorta was immediately removed into ice cold 
Krebs bicarbonate buffer, cleaned of connective 
tissue, and dissected into 2-3mm long rings.
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The aortic rings were then randomly placed in 3 
different solutions for incubation:
Incubation for Vascular Response Experiments
Approx. No. Rings 
Per Experiment
3 2 3
Solution
Krebs
Control
ox-LDL/LDL ox-LDL/LDL
Contents
Krebs
bicarbonate
buffer
(KBB)
+ /- Vit. E 
Dex.
SOD
100ng/ml 
ox-LDL/LDL 
+ KBB
500pg/ml 
ox-LDL/LDL 
+ KBB
+ /- Vit. E 
Dex. 
SOD
Volume 1ml 1ml 1ml
TABLE 2.2 - Incubation set up for experiments studying the 
effect of cholesterol on vascular responses
NOTE - where controls had no additional compound, appropriate 
concentration of vehicle added.
Experiments were also conducted using a 20fig/ml 
ox-LDL solution. Preincubation control rings were 
examined, and dexamethasone experiments were carried 
out in the presence and absence of endothelium.
Rings were incubated in the above solutions for 5 
hours at 37°C in 95%Air/5%C02. Tubes were mixed by
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inversion every 30 minutes to ensure adequate 
oxygenation.
In vitamin E/LDL studies 4|jM final concentration of 
EDTA and BHT was added to solutions immediately 
following incubation and removal of rings to prevent 
further oxidation. Levels of incubation-induced 
oxidation were measured using a modified TBA assay 
with appropriate ox-LDL and preincubation controls 
(see 2.2.8.).
Rings were suspended in 10ml organ baths containing 
Krebs bicarbonate buffer (see appendix 7) at 37°C, 
and continuously gassed with 95%02/5%C02.
Isometric tension was recorded using a force 
transducer (Grass model FT03) connected to a chart 
recorder (Grass polygraph model 7B) . Tissues were 
stretched to a resting tension of lg and were left 
to equilibrate for 1 hour. During this time tissues 
were washed and restretched every 15 minutes.
Tissues were 'primed’ with a 5xlO"7M concentration of 
phenylephrine. Cumulative concentration-response 
curves were constructed to phenylephrine, carbachol, 
SNP, and potassium chloride. L-NAME induced
43
F
lu
o
re
sc
en
ce
Lipid Perox idat ion  Assay Stan dar d  Curve  
n=4
35
30
25
20
15
10
5
0
0.750.45 0.600.15 0.300.00
Malondialdehyde (nmoles)
Example of standard curve for lipid peroxidation (TBA) assay. 
In general, samples fell on lower half of the curve.
contraction was also measured. (NOTE- L-NAME and SNP 
responses measured in different tissues).
Following experimentation tissues were removed, 
blotted dry and weighed. Their wet weight was used 
to calculate results 'per O.lg tissue'.
2.2.8 ASSAY FOR LIPID PEROXIDATION LEVELS (TBA TEST)
Oxidation was measured by a modification of Ohkawa's 
spectrophotometric method (Ohkawa et al., 197 9, 
Shad, 1993).
A standard curve was prepared using malondialdehyde 
(MDA) to calibrate the reaction. Points on the 
standard curve were 0, 0.05, 0.1, 0.15, 0.2, 0.25,
0.3, 0.4, 0.5, 0.6, 0.7nmo1es MDA.
500|ils of each sample and standard were added to
assay tubes, 800jils of sodium dodecyl sulphate (SDS) 
(see appendix 8) added, and the tubes vortex mixed. 
3mls of 0.8% TBA acetic acid was then added to each 
tube, the tubes vortex mixed, and heated at 95°C for 
60 minutes.
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Following incubation 1ml of dH20 followed by 2.5mls 
buton-l-ol was added, tubes mixed, and centrifuged 
at 10°C, 2000rpm (500g) for 5 minutes.
The top layer (organic) was removed and measured for 
fluorescence at 515-553nm.
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3
MEMBRANE CHOLESTEROL ALTERATIONS IN 
WKY AND SHRSP VASCULAR SMOOTH MUSCLE 
CELLS ON EXPOSURE TO NATIVE AND 
OXIDISED LDL
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3.1 INTRODUCTION
The first indication of atherosclerosis is the
accumulation of lipid in the intima of susceptible 
arteries. These fatty streaks classified by the
World Health Organisation as stage 1 of
atherosclerosis, are characterised by extracellular 
and intracellular lipids and are usually covered by 
intact endothelium. The lipid is predominantly 
derived from LDL of the plasma (Cardona-Sanclemente 
and Born, 1996) .
Smooth muscle cells are the predominant cell type in 
the intima and media of large arteries and are also
the cell type which proliferates early in the
development of atheroma. During the progression of 
atherosclerotic disease they become an increasingly 
important cell type, accounting for a substantial 
proportion of cells within the atherosclerotic 
plaque.
Various groups have shown that increased cholesterol 
content within the cell membrane may be an initiator 
of proatherogenic changes at the level of membrane 
physicochemical structure and calcium influx 
(Scott-Burden et al., 1989, Yeagle, 1989; Bialecki 
et al., 1991, Figueiredo et al., 1991; Thorin et
al., 1995). Changes observed following cholesterol
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exposure range from alterations in Na-H antiporter 
activity and intracellular calcium, to activation of 
phosphatidylinositol metabolism and induction of 
growth-related metabolism.
The mechanism(s) responsible for cholesterol 
accumulation within arterial cells are not fully 
understood.
Most cells are known to have specific apolipoprotein 
(apo) B and apo E receptors on their surface (ie. 
the LDL receptor), however the activity of this 
receptor is inversely proportional to the 
cholesterol level in the cell. It is therefore 
unlikely that LDL receptor-mediated uptake can 
solely account for the observed cholesterol 
accumulation in cells (Slotte et al., 1988).
Macrophages (the dominant cell type of 
atherosclerotic 'foam cells') have acetyl LDL 
receptors (also known as scavenger receptors) that 
bind and take up several modified forms of LDL, of 
which oxidative modification is prominent. The 
activity of this receptor does not alter with 
changes in cell cholesterol content, and leads to 
massive cholesterol accumulation and foam cell 
formation. Groups such as Brown et al., 1983, and
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Slotte et a l., 1988, have suggested that arterial
smooth muscle cells lack such acetyl LDL receptors, 
and that cholesterol uptake is via a 
receptor-independent mechanism. This would allow 
arterial smooth muscle cells to take up LDL in both 
its native and oxidised form to a similar extent. 
Indeed, work by Fischman et al., 1985, showed that
the distribution and intensity of. native and 
methylated LDL accumulation in the arterial wall of 
rabbit aorta was the same.
Acetyl LDL receptors are, however, expressed on cell 
types other than macrophages.
Stein and Stein, 1980, and more recently Thorin et 
al., 1995, have shown preferential uptake of
modified LDL over native LDL in bovine endothelial 
cells. Thorin et al., found that free cholesterol 
content increased by 35% and 100% in LDL and ox-LDL 
treated cells respectively, suggesting the presence 
of acetyl LDL receptors on this cell type.
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More interestingly, Pitas, 1990, found acetyl LDL 
receptor expression on both rabbit fibroblasts and 
smooth muscle cells. This expression could be 
up-regulated by both serum and phorbol esters, 
suggesting that vascular smooth muscle cells can 
express the acetyl LDL receptor, and that receptor 
expression can be regulated.
Hypertension is also a well known risk factor, 
especially when associated with hypercholesterolemia 
(Hollander et al., 1976; Chobanian, 1983; McGill et 
al., 1985; Kannel and Sytkowski, 1987; Chobanian et 
al., 1989). Mechanisms by which hypertension 
contributes to atherogenesis have not been 
established, however a synergy between the two risk 
factors has been suggested. Since uptake of LDL is 
an important primary event in the atherosclerotic 
process it is possible that hypertension could 
accelerate the disease process by increasing 
cholesterol uptake by cells.
Studies by Dominiczak et al., 1993, found that
membrane microviscosity was elevated (ie. decreased 
membrane fluidity) in vascular smooth muscle cells 
from stroke-prone spontaneously hypertensive (SHRSP) 
rats when compared with cells from Wistar-Kyoto 
(WKY) rats, a normotensive reference strain.
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This, and other studies (McLaren et a l., 1993,
Devynck et al., 1982), suggest that hypertension 
causes alterations in physicochemical structure of 
the lipid bilayer. As mentioned previously, similar 
alterations have also been observed following 
increased cholesterol content of cell membranes.
3.2 AIMS
The aim of this study was to investigate vascular 
smooth muscle cholesterol uptake by comparing the 
effects of native and oxidised LDL on free and total 
membrane cholesterol levels.
Hypertension and hypercholesterolemia were also 
examined as coexisting and interactive risk factors 
using a multiple risk model.
3.3 METHODS
Cells were cultured, LDL and ox-LDL prepared, and 
experimental protocols carried out as described 
previously (see 2.2.1-2.2.4, 2.2.6).
On reaching confluence WKY and SHRSP VSM cells were 
incubated for 24 hours in medium 199 containing
either vehicle control, 20|ig/ml LDL, or 2 0^g/ml 
ox-LDL.
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Following incubation cells were scraped from plates, 
and free membrane cholesterol measured by enzymatic 
fluorescence assay determination. Protein content 
was measured using a modified Lowry assay.
3.4 DATA CALCULATION AND STATISTICS
Results were expressed in 'fag cholesterol per mg 
protein’ . The mean for each incubation group was 
calculated + /- standard error of the mean (SEMEAN).
Statistical analysis was carried out using repeated 
measures ANOVA, and Bonferroni paired multiple 
comparison tests (differences being considered 
significant when p<0.05).
Results were also calculated as a ’% increase in 
cell cholesterol content’. The median for each 
incubation group was calculated and 1st and 3rd 
quartile values given.
Statistical analysis was carried out using 1-sample 
Wilcoxon signed rank confidence interval tests, and 
Mann-Whitney 2-sample tests (with Bonferroni 
correction for multiple comparisons).
(Note - in cell culture experiments cells were 
derived from a minimum of 4 rats per experimental 
set) .
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3.5 RESULTS
Small increases in free membrane cholesterol were 
observed on exposure of WKY and SHRSP vascular 
smooth muscle cells to both LDL and ox-LDL (Fig.
3.1) .
Both WKY and SHRSP cells had similar basal 
cholesterol levels (no significant difference), 
which increased following a 24 hour incubation with
20ng/ml LDL or ox-LDL. This reached significance in 
the SHRSP cells following LDL and ox-LDL treatment, 
while WKY cells showed a similar trend.
’Percentage increase in free membrane cholesterol 
content1 was also examined following LDL and ox-LDL 
treatment (Table 3.1).
Free cell cholesterol content of SHRSP VSM cells 
increased significantly after LDL and ox-LDL 
treatment by 31.15% and 43.35% respectively. WKY VSM 
cells showed a smaller but similar trend (18.27% and 
17.6% respectively).
In both cell types there was no significant 
difference between LDL and ox-LDL treatment.
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Cholestero l  Upta ke
n = 2 4 /2 0
Cholesterol 
(fjg per mg protein)
PBS LDL ox-LD L
2 0 p g / m l
F I G .  3 . 1  - Effect of LDL and ox-LDL (20fig/ml) on free 
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Solid bars represent WKY and open bars 
represent SHRSP.
* Significant difference from PBS/control (p<0.05)
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Percentage Change in free membrane Cholesterol Content
WKY SHRSP
LDL ox-LDL LDL ox-LDL
Median 18.2 17.6 31.15* 43.35*
Q1 -6.4 3.8 2.55 12.75
Q3 47.4 42.1 53.45 55.8
C.I. -0.7 -2 . 6 3.6 15.6
47 51.9 56.8 67.5
TABLE 3.1 - Percentage increase in free membrane cholesterol 
in cultured vascular smooth muscle cells on exposure to 20p.g/ml 
LDL/ox-LDL.
* Significant increase from control (p<0.05)
C.I. 95% confidence intervals
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Total membrane cholesterol content was also measured 
(not shown) and expressed a similar trend.
3.6 DISCUSSION
On exposure of vascular smooth muscle cells to 
2 0|ig/ml LDL/ox-LDL small increases in free membrane 
cholesterol content were observed.
This equated to 18.27% and 17.6% in WKY VSM cells 
following LDL and ox-LDL treatment respectively. 
These results confirm those of groups such as Alam 
et al., 1980, who observed an increase in free 
membrane cholesterol content of 44.8% following a 24 
hour incubation of human VSM cells with plasma LDL
at the higher concentration of 400|ag/ml.
Having carried out studies with plasma LDL 
concentrations ranging from 200jj,g/ml-800|j.g/ml, Alam 
et al., noted that cellular cholesterol content was 
dose dependent, which may explain the higher value 
observed when compared with the present study. The 
following study therfore substantiates the findings 
of such groups.
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As already mentioned treatment of WKY VSM cells with 
LDL and ox-LDL produced similar increases in free 
membrane cholesterol content.
This is similar to the findings of Fischman et al., 
1985, who found that distribution and intensity of 
native and methylated LDL accumulation were the same 
in the rabbit aortic wall. Results from this study, 
therefore support the theory that vascular smooth 
muscle cells may not normally express acetyl LDL 
receptors, but can accumulate cholesterol via a 
receptor-independent mechanism.
The aim of this study was also to examine 
hypertension and hypercholesterolemia as coexisting 
and interactive risk factors using a multiple risk 
model.
Incubation of SHRSP VSM cells with LDL and ox-LDL 
produced increases in free cholesterol content of 
31.15% and 43.35% respectively, suggesting greater 
changes in cellular cholesterol content following 
LDL/ox-LDL exposure than observed in VSM cells from 
WKY rats, a normotensive reference strain.
Numerous studies have shown structural alterations 
in the cell membranes of SHRSP rats.
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For example, decreased lateral diffusion (decreased 
membrane fluidity) has been observed in SHRSP cells 
when compared with WKY cells - their normotensive 
control (Dominiczak et al., 1993; McLaren et al., 
1993) .
Berk et al., 1989, found that cultured VSM cells 
from spontaneously hypertensive rats exhibited 
increased growth and Na+/H+ exchange.
Such data are consistent with alterations in membrane 
physicochemical structure observed following 
increased cholesterol content.
Since changes in cell membrane cholesterol content 
have been shown to alter membrane physiochemical 
structure (see introduction 3.1), these results 
indicate a possible interactive mechanism between 
hypertension and hypercholesterolemia, whereby 
hypertension could accelerate atherosclerotic 
progression by increasing cholesterol uptake by 
cells.
Incubation of SHRSP VSM cells with ox-LDL also 
tended to result in a greater % increase in cellular 
free cholesterol content when compared with LDL
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treatment (43.35% vfs 31.15% respectively), although 
this was not statistically significant.
A possible theory which would explain such results 
may be that SHRSP VSM cells express a small number 
of acetyl LDL receptors, however further work would 
be required to substantiate any such theory.
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4
EFFECTS OF VITAMIN E AND 
n-ACETYLL CYSTEINE ON MEMBRANE 
CHOLESTEROL
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4.1 INTRODUCTION
In recent years considerable international interest 
has grown in the possibility that some of the major 
chronic disease states that afflict mankind 
worldwide, may be preventable by increasing intake 
of antioxidants.
Free radicals have been implicated as a contributing 
factor to the pathophysiology of diseases ranging 
from stroke and cancer to respiratory and 
cardiovascular disease. Antioxidant neutralisation 
of such free radicals may therefore prevent and 
protect against these associated disease states.
Since the mid 1980Ts there has been an explosion in 
the number of studies investigating antioxidant 
protection, in particular against cardiac and 
circulatory disease. Antioxidants studied include 
chemical antioxidants such as DPPD, probucol (and 
structurally related compounds such as BHT), and 
natural dietary antioxidants such as the vitamins A, 
C, and E, carotenoids (in particular beta-carotene), 
and the trace mineral selenium.
DPPD, BHT, and probucol have all been shown to 
decrease the degree of LDL oxidation and to protect 
against the progression of atherosclerotic disease
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in animal models (Carew et a l ., 1987; Kita et al.,
1988; Steinberg et al., 1988; Bjorkhem et al., 1991; 
Sparrow et al., 1992; Plane et al., 1993).
Although effective in the prevention of 
atherosclerosis DPPD has been shown to be mutagenic 
(Rannug et al., 1984), and BHT can cause 
considerable acute toxicity in animals (although 
studies also suggest negligible chronic toxicity at 
the maximum acceptable daily intake for man) (Hirose 
et al., 1981) .
Probucol, a hypolipidemic drug, and the most 
extensively studied of the chemical antioxidants, 
was found to have marked antioxidant activity in 
humans, however also caused substantial lowering of 
HDL cholesterol (Reaven et al., 1992; Walldius et
al., 1993). The significance of this lowering is 
unknown, however HDL is thought to protect against 
atherosclerotic disease and studies have shown that 
a low HDL cholesterol level is linked to an 
increased risk of coronary artery disease (Kannel 
et al., 1979).
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Given the toxicity and potential side effects of the 
chemical antioxidants their use as preventative 
agents in man is very limited.
As a result interest has turned towards the natural 
dietary antioxidants. High doses of these nutrients 
are well tolerated and without serious adverse
reactions (Bendich and Machlin, 1988; Hathcock et 
al., 1990; Walter, 1991; Diplock, 1995).
Evidence suggests that the presence of the 
antioxidant vitamins C and E, and beta-carotene in 
the blood may have a protective role against
cardiovascular disease (reviewed by Rice-Evans, 
1995).
Numerous studies have been carried out examining 
effects and actions of these antioxidants
individually and in combination with varying 
results.
Data collected from the World Health Organisation 
MONICA . study for example,found that plasma vitamin E 
exhibited a strong inverse correlation with the risk of 
ischaemic heart disease. Vitamin C also showed a
moderately strong statistically significant inverse
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correlation, whereas vitamin A and carotene showed 
only a weak inverse correlation (Gey et al., 1991).
Rimm et al., 1993, using data generated from the 
Health Professionals Study, also found a strong 
association between higher intake of vitamin E and a 
lower risk of coronary artery disease. However, 
beta-carotene was associated with a significantly 
lower risk of coronary artery disease among current 
and former smokers, wheras vitamin C showed no 
association with lower risk among any of the 
population groups.
As a result the cardiovascular protective effects of 
these antioxidants remains controversial, however 
vitamin E stands out - producing the most consistent 
results, for the prevention of LDL oxidation and 
atherosclerotic development and progression (Belcher 
et al., 1993; Ferns et al., 1993; Reaven et al.,
19931; Rimm et al., 1993; Stampfer et al., 1993; 
Andersson et al., 1994; Jialal and Fuller, 1995;
Stephens et al., 1996).
a-tocopherol is the most prevalent and biologically 
active form of vitamin E. It is the predominant 
lipid soluble antioxidant in tissues, and is present
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in blood plasma in the LDL fraction. Vitamin E is 
therefore, optimally placed to prevent free radical 
mediated modification of LDL and tissue damage 
(Ferns et al., 1993).
There is increasing evidence indicating that LDL 
oxidation, which occurs during atherosclerosis and 
is thought to be involved in lesion initiation and 
progression, is inhibited by vitamin E (Reaven et 
al., 19931, 19932; McDowell et al., 1994; Suzukawa et 
al., 1994; Parker et al., 1995).
Recent studies have also suggested that vitamin E 
may have other anti-atherogenic effects.
Physiological concentrations of alpha-tocopherol 
have been shown to inhibit smooth muscle cell 
proliferation and protein kinase C activity (Ozer et 
al., 1993; Boscoboinik et al., 1994, 1995).
Thorin et al., 1995, observed that increased free
cholesterol content in LDL and ox-LDL treated bovine 
aortic endothelial cells could be prevented by 
addition of vitamin E during the treatment period. 
Ox-LDL mediated alterations in membrane 
microviscosity were also blocked by addition of 
vitamin E (and the microviscosity of all cells
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reduced). In addition vitamin E was shown to affect 
basal and stimulated intracellular calcium 
concentrations in normal cells. These results 
suggest an additional role of vitamin E in
cholesterol flux alterations of the cell membrane.
Investigation into the non-antioxidant
anti-atherogenic effects of vitamin E is however, 
relatively recent, and much work is still required 
before its full effects and actions are uncovered.
Another antioxidant of increasing interest in recent 
years is that of N-acetyl-l-cysteine (NAC).
A potential therapeutic agent in antioxidant 
mediated disorders, NAC has been widely used as a 
mucolytic drug for the treatment of chronic
obstructive lung disease, and has been shown to reduce 
the suceptibility of lung tissue to free
radical-induced damage by potentiating antioxidant 
defence systems (Sala et al., 1993).
4.2 AIMS
The aim of this study was to investigate the effects 
of the antioxidants vitamin E and NAC on LDL and 
ox-LDL mediated cholesterol uptake in WKY and SHRSP 
vascular smooth muscle cells.
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4.3 METHODS
Cells were cultured, LDL and ox-LDL prepared, and 
experimental protocols carried out as described 
previously (see 2.2.1-2.2.4, 2.2.6).
On reaching confluence WKY and SHRSP VSM cells were 
incubated for 24 hours in medium 199 containing
20|ug/ml LDL or ox-LDL. Experiments were also carried
out in the presence and absence of 10 and IOOjjM 
vitamin E or NAC. Appropriate controls were used for 
each experiment.
Following incubation cells were scraped from plates, 
and free membrane cholesterol measured by enzymatic 
fluorescence assay determination. Protein content 
was measured using a modified Lowry assay.
4.4 DATA CALCULATION AND STATISTICS
Results were expressed in ’ (ig cholesterol per mg 
protein’ . The mean for each incubation group was 
calculated +/- standard error of the mean (SEMEAN).
Statistical analysis was carried out using repeated 
measures ANOVA, and Bonferroni paired multiple 
comparison tests (differences being considered 
significant when p<0.05).
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Results were also calculated as a ' % 
increase/decrease in cell cholesterol content'. The 
median for each incubation group was calculated and 
1st and 3rd quartile values given.
Statistical analysis was carried out using 1-sample 
Wilcoxon signed rank confidence interval tests, and 
Mann Whitney 2-sample tests (with Bonferroni 
correction for multiple comparisons).
4.5 RESULTS
4.5.1 EFFECTS OF VITAMIN E ON LDL- INDUCED 
CHOLESTEROL UPTAKE
Vitamin E abolished any LDL effect at both 10 and 
lOOpM concentrations, but also appeared to reduce 
basal free membrane cholesterol.
At the lOpM concentration vitamin E abolished any 
LDL-mediated increase in cholesterol content (Fig.
4.1). A significant reduction in free cholesterol 
content was observed when both WKY and SHRSP VSM 
cells were incubated with LDL in the presence of
lOfiM vitamin E when compared with LDL alone.
Interestingly, vitamin E also showed a tendency to 
reduce basal free cholesterol levels. Results
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FIG. 4.1 - Effect of LDL (20fi,g/ml) +/- lOfiM vitamin E on free 
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Where solid bars represent WKY and open 
bars represent SHRSP.
* significant difference from LDL sample set (p<0.05).
FIG. 4.2 — Effect of LDL (20|j,g/ml) +/- lOOfiM vitamin E on
free membrane cholesterol content in WKY and SHRSP cultured 
vascular smooth muscle cells. Where solid bars represent WKY 
and open bars SHRSP.
O significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
12 n
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suggest that vitamin E-treated WKY and SHRSP VSM 
cells had a lower free cholesterol content than that 
of control cells, however this did not reach
significance.
Incubation with a higher (lOO^M) concentration of 
vitamin E showed a similar trend (Fig. 4.2).
A significant reduction in free cholesterol content 
was again observed when both WKY and SHRSP VSM cell 
were incubated with LDL and vitamin E compared with 
LDL alone.
Vitamin E showed a tendency to reduce basal free 
cholesterol levels in both cell types, reaching
significance in WKY cells.
Results were also expressed as a 'percentage 
increase/decrease in free membrane cholesterol
content' following LDL +/- vitamin E treatment 
(Tables 4.1 & 4.2) .
As previously, any increase in free cholesterol 
following LDL treatment in WKY VSM cells was again,
abolished by vitamin E at both 10 and 100|jM 
concentrations. SHRSP VSM cells appeared to show a 
similar trend (however no % increase in free
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Percentage Change in Free Membrane Cholesterol Content 
10|iM Vitamin E
WKY SHRSP
vit. E LDL LDL/E vit. E LDL LDL/E
Median -13.6 40.9 -39.3*0 -25.5 1.8 -24.7
Qi -62.4 7.9 -66.9 -36.4 -19.4 -46.8
Q3 -4.2 119.5 -25.5 -8.4 16.2 -9.8
C.I. -72.1 7 -93 -40.9 -19.5 -69
0 180 -14.3 21.5 28.9 7.9
TABLE 4.1 — Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20fxg/ml LDL +/- lOfiM vitamin E.
0  significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
C.I. 95% confidence intervals
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Percentage Change in Free Membrane Cholesterol Content 
100|iM Vitamin E
WKY SHRSP
vit. E LDL LDL/E vit. E LDL LDL/E
Median -69.8 0 10.5 -65.8*0 -55.5 -13.2 -67
Q1 -79.5 -30.5 i 0
0 00 -74.6 -52.4 -84.1
Q3 -48.3 40.8 -41.1 -35.9 50.1 -9.3
C.I. -86.5 -40 -82.8 -79 -83 -89
-32.7 65 -17.9 84 226 65
TABLE 4.2 - Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20|xg/ml LDL +/- lOOfiM vitamin E.
0 significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
C.I. 95% confidence intervals
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cholesterol content was observed following 
incubation of SHRSP VSM cells with LDL in these 
experimental subgroups).
WKY VSM cells treated with LDL and vitamin E (10 and 
100 pM concentrations) , also had significantly lower 
free cholesterol content than that of control cells 
(39.3% and 65.8% decrease in free cholesterol 
content respectively).
Treatment of WKY and SHRSP VSM cells with lOpM 
vitamin E only, resulted in a decrease in free 
cholesterol content of 13.6% and 25.5% respectively.
At the higher treatment concentration of lOOpM 
vitamin E, free cholesterol content was reduced by 
69.8% in WKY, and 55.5% in SHRSP cells, suggesting a 
possible concentration-dependent effect. Reduction 
of free cholesterol content in WKY cells at this 
concentration was statistically significant.
4.5.2 EFFECTS OF VITAMIN E ON OX-LDL-INDUCED 
CHOLESTEROL UPTAKE
Vitamin E attenuated any effect at both 10 and lOOpM 
concentrations, but also appeared to reduce basal 
free membrane cholesterol levels.
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At the 10|oM concentration vitamin E attenuated any
ox-LDL-mediated increase in cholesterol content 
(Fig. 4.3). A significant reduction in free 
cholesterol content was observed when SHRSP VSM 
cells were incubated with ox-LDL in the presence of
IOjXM vitamin E (when compared to ox-LDL alone) , 
while WKY VSM cells showed a similar trend.
Vitamin E also showed a tendency to reduce basal 
free cholesterol levels; results suggesting that 
vitamin E-treated WKY and SHRSP VSM cells had a 
lower free cholesterol content than that of control 
cells.
Incubation with a higher (IOOjXM) concentration of 
vitamin E showed a more prominent trend (Fig. 4.4).
A significant reduction in free membrane cholesterol 
content was observed when both WKY and SHRSP VSM
cells were incubated with ox-LDL and vitamin E,
compared with ox-LDL alone.
Vitamin E significantly reduced basal free
cholesterol levels in both WKY and SHRSP VSM cells.
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{pg per mg protein)
CONTROL Vit.E (10yM ) ox -L D L  o x -L D L /V it. E
FIG. 4.3 - Effect of ox-LDL (20|xg/ml) +/- 10|iM vitamin E on 
free membrane cholesterol content in WKY and SHRSP cultured 
vascular smooth muscle cells. Where solid bars represent WKY 
and open bars represent SHRSP.
O significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05) .
Cholesterol Uptake
12 -i n = 7 /7
Cholesterol 
tpg per mg protein)
CONTROL Vit.E dO O flM ] o x -L D L  o x -L D L /V it. E
FIG. 4.4 - Effect of ox-LDL (20|ig/ml) +/- lOOjiM vitamin E on 
free membrane cholesterol content in WKY and SHRSP cultured 
vascular smooth muscle cells. Where solid bars represent WKY 
and open bars SHRSP.
O significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
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Results were also expressed as a ’percentage 
increase/decrease in free membrane cholesterol 
content' following ox-LDL +/- vitamin E treatment 
(Tables 4.3 & 4.4).
As previously, results showed that any increase in 
free cholesterol content following ox-LDL treatment, 
in both WKY and SHRSP VSM cells, was attenuated by
vitamin E at both 10 and 100|iM concentrations.
At the 10|jM vitamin E concentration a significant 
attenuation of ox-LDL-mediated change in free 
membrane cholesterol was observed in SHRSP VSM 
cells. WKY VSM cells showed a similar trend.
At the higher (lOOjiM) concentration a significant 
attenuation of ox-LDL-mediated effects were observed 
in both WKY and SHRSP VSM cells.
Treatment of WKY and SHRSP VSM cells with 10(jM 
vitamin E alone, suggested a decrease in free 
cholesterol content (-15.5% and -33.9%
respectively).
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Percentage Change in Free Membrane Cholesterol Content 
IO i^ M Vitamin E
WKY SHRSP
v i t .  E ox -L D L o x /E v i t .  E ox -L D L o x /E
Median -15.5 52.7 0 -7.8 -33.9 50.3 0 -39.3*0
Q1 -35.2 23.5 -22.7 -63.9 14.3 -87.4
Q3 -4.3 147.6 75.7 -14.1 75.9 -22.5
C.I. -38.5 19 -35 -65.3 14.3 -96.4
1.6 218 142 9.8 78.6 -4.3
TABLE 4 . 3  - Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20p.g/ml ox-LDL +/- 10|iM vitamin E.
O significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
C.I. 95% confidence intervals
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Percentage Change in Free Membrane Cholesterol Content 
lOOjiM Vitamin E
WKY SHRSP
vit. E ox-LDL ox/E vit. E ox-LDL ox/E
Median -67.2 0 7.41 -56.5* -89.9 0 13.9 -73.5*
Q1 -88.9 -4.04 -92.2 -92.8 6.1 -91.8
Q3 -30.8 29.4 -9.1 -38.2 68.4 -52
C.I. -92 -20 -98 -97.1 -21 -93
-11.2 31.7 7 -10.2 90 81
TABLE 4.4 - Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20(j,g/ml ox-LDL +/- 100|iM vitamin E.
0 significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
C.I. 95% confidence intervals
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This reached significance in the IOOjoM vitamin E 
treated cells (-67.2% and -89.9% respectively), 
suggesting a concentration-dependent effect.
4.5.3 EFFECTS OF NAC ON LDL-INDUCED CHOLESTEROL 
UPTAKE
The effects of NAC on LDL-mediated increases in free 
cholesterol content were minimal at both 10 and
lOOfiM concentrations. No significant alteration in 
basal free cholesterol content was observed 
following NAC treatment alone.
Data suggested a very small attenuation of 
LDL-mediated free cholesterol changes at lOfiM NAC in
SHRSP VSM cells, and to a greater extent at IOOjjM 
NAC in both cell types (Figs 4.5 & 4.6) . observed 
changes were minimal and did not reach significance.
No effect on WKY or SHRSP basal free cholesterol 
content was observed following NAC-treatment at 
either concentration.
Results were also expressed as a 'percentage 
increase/decrease in free membrane cholesterol 
content' following LDL +/- NAC treatment (Tables 4.5 
& 4.6) .
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FIG. 4.5 - Effect of LDL (20jJ.g/ml) +/- 10|iM NAC on free
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Where solid bars represent WKY and open 
bars represent SHRSP.
O significant difference from control (p<0.05)
Cholesterol Uptake
12 -i n - 5 /5
Cholesterol 
(pg per mg protein)
CONTROL NAC (100p M ) LDL LDL/N A C
FIG. 4.6 - Effect of LDL (20|J.g/ml) +/- 100|iM NAC on free
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Where solid bars represent WKY and open 
bars SHRSP.
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Percentage Change in Free Membrane Cholesterol Content
10ilM NAC
WKY SHRSP
NAC LDL LDL/N NAC LDL LDL/N
Median 7.9 7.1 29.8 26.2 52.5 0 17.1
Q1 -44.9 -16.2 -51.4 2.6 11.3 2.2
Q3 18.7 51.6 65.8 35.5 145.6 56.8
C.I. -14.9 -35.1 -29.9 -16 11 -14
72.7 59 25 74.3 261 158
TABLE 4.5 - Percentage increase in free membrane cholesterol 
in cultured vascular smooth muscle cells on exposure to 20p.g/ml 
LDL +/- 10pM NAC.
0 significant difference from control (p<0.05)
C.I. 95% confidence intervals
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Percentage Change in Free Membrane Cholesterol Content
100}iM NAC
WKY SHRSP
NAC LDL LDL/N NAC LDL LDL/N
Median -9.5 27 3.5 6.8 12 -20
Q1 -13.7 -13.2 -20.65 -13 -19.6 -31.4
Q3 35 50 18.05 16.3 147.6 40.2
C.I. -14.9 -35.1 -29.9 -28.4 -20 -36
72.7 59 25 22. 6 261 93
TABLE 4.6 - Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20|xg/ml LDL +/- 100|iM NAC.
C.I. 95% confidence intervals
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As previously, data suggested a minimal reduction in 
LDL-mediated effects following treatment with lOpiM 
NAC in SHRSP VSM cells (LDL 52.5%, LDL/NAC 17.1% 
change in free cholesterol content).
Following IOOjjM NAC treatment a minimal reduction 
was observed in both cell types (WKY: LDL 27,
LDL/NAC 3.5; SHRSP: LDL 12, LDL/NAC -20%). Such
changes were not significant.
Data suggested a minimal reduction in basal free 
cholesterol following 10|uM NAC treatment in SHRSP
and lOOfiM NAC treatment in SHRSP and WKY VSM cells. 
Such changes were not significant.
4.5.4 EFFECTS OF NAC ON OX-LDL-INDUCED CHOLESTEROL 
UPTAKE
NAC attenuated any ox-LDL effect at the 100|uM 
concentration only. No alteration in free 
cholesterol content was observed following NAC 
treatment alone.
10(1M NAC had no observable effect on ox-LDL-mediated 
increases in free cholesterol content in either WKY 
or SHRSP VSM cells (Fig. 4.7).
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FIG. 4.7 - Effect of ox-LDL (20(xg/ml) +/- 10|iM NAC on free
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Where solid bars represent WKY and open 
bars represent SHRSP.
Cholesterol Uptake
n = 6 /6
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FIG. 4.8 - Effect of ox-LDL (20(ig/ml) +/- lOOjiM NAC on free
membrane cholesterol content in WKY and SHRSP cultured vascular 
smooth muscle cells. Where solid bars represent WKY and open 
bars SHRSP.
O significant difference from control (p<0.05)
* significant difference from LDL sample set (p<0.05)
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At the higher (IOOjjM) concentration of NAC a 
significant reduction in free cholesterol content 
was observed when SHRSP VSM cells were incubated
with ox-LDL in the presence of lOOpM NAC when 
compared with ox-LDL alone (Fig. 4.8). WKY VSM cells 
showed a similar trend.
No effect on basal free cholesterol content was 
observed following NAC treatment at either
concentration.
Results were also expressed as a 'percentage 
increase/decrease in free membrane cholesterol 
content’ following ox-LDL +/- NAC treatment (Tables 
4.7 & 4.8).
As previously, data suggested a small reduction in 
ox-LDL mediated effects following treatment with the
higher (IOOjjM) NAC concentration only. Small
reductions in ox-LDL mediated effects were observed 
in both WKY and SHRSP VSM cells (as a %
increase/decrease in free cholesterol content; WKY: 
ox-LDL 28.7, ox/NAC -0.1; SHRSP: ox-LDL 32.7, ox/NAC 
13.1), but did not reach significance.
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Percentage Change in Free Membrane Cholesterol Content
10iiM NAC
WKY SHRSP
NAC ox-LDL ox/N NAC ox-LDL ox/N
Median 18.3 9.3 13.1 2 12.2 34.7
Q1 -39.9 -13 -34.8 -14.3 -20.6
1 1—* 00
Q3 77.4 30 60.9 12.5 32.6 44.3
C.I. -48 -40.4 -45 -26.7 -29 -38
79 31.7 158 28.7 90 73
TABLE 4.7 - Percentage increase in free membrane cholesterol 
in cultured vascular smooth muscle cells on exposure to 20(j,g/ml 
ox-LDL +/- lO^M NAC.
C.I. 95% confidence intervals
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Percentage Change in Free Membrane Cholesterol Content
100|iM NAC
WKY SHRSP
NAC ox-LDL ox/N NAC ox-LDL ox/N
Median -4.83 28.7 -0.1 1.8 32.7 0 13.1
Q1 -28.95 -2.7 -46.1 -25.1 17.8 -14.3
Q3 17.28 64 53.4 34.6 111.2 41.7
C.I. -29.7 -14 -47 -42.1 5 -49
17.5 98 82 49.6 153 52
TABLE 4.8 — Percentage increase/decrease in free membrane 
cholesterol in cultured vascular smooth muscle cells on 
exposure to 20jxg/ml ox-LDL +/- lOO^M NAC.
0 significant increase from control (p<0.05)
C.I. 95% confidence intervals
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Data suggested a minimal reduction in basal free 
cholesterol following lOpM NAC treatment in SHRSP,
and 100|iM NAC treatment in SHRSP and WKY VSM cells, 
however, no significant difference was observed.
4.6 DISCUSSION
In chapter 3 it was shown that exposure of vascular 
smooth muscle cells to 20jig/ml LDL/ox-LDL produced 
small increases in free membrane cholesterol 
content.
The aim of the present study was to investigate the 
effects of the antioxidants vitamin E and NAC on LDL 
and ox-LDL mediated cholesterol uptake in WKY and 
SHRSP VSM cells.
Results were expressed in 'fig cholesterol per mg 
protein’ and as a 'percentage increase/decrease in 
cell cholesterol content’ to give a more critical 
interpretation of data, and allow a clearer analysis 
of results.
Due to smaller experimental subsets, and variation 
in responses observed to LDL and ox-LDL, results did 
not always reach statistical significance. This made 
interpretation of data harder, however, by
expression of data in 2 ways certain patterns 
clearly emerged.
Variation in responses observed to LDL and ox-LDL 
may be due to differences in cell source (ie. 
intraspecies variation), or rate of growth and 
health of cells at the time of incubation.
Alternatively, interbatch differences in LDL and 
ox-LDL could account for such variation in results.
As previously mentioned, LDL and ox-LDL were 
regularly prepared from numerous healthy 
normolipidaemic volunteers, and it is likely that 
genetic variation and differences in lifestyle will 
cause considerable intersample diversity.
Additionally, ox-LDL is not a single homogeneous 
entity, and considerable variation may occur from 
preparation to preparation even when every effort is 
made to hold conditions constant.
The present study demonstrated that in the presence 
of either 10 or 100(jM vitamin E, LDL and ox-LDL 
mediated effects were attenuated.
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These results are similar to those of Thorin et al.,
1995, who found that when vitamin E (IOOjjM) was 
added together with LDL/ox-LDL to bovine aortic 
endothelial cells for a 3 day incubation period, the 
increase in cell free cholesterol content in both 
LDL and ox-LDL treated cells was completely
reversed. However, IOjjM concentrations of vitamin E 
reversed ox-LDL induced increases in cell free 
cholesterol content only.
Due to the action of vitamin E on both LDL and 
ox-LDL mediated increases in cell free cholesterol 
content, effects cannot be attributed to vitamin E’s 
antioxidant properties, and therefore suggest other 
mechanisms of action.
Traber and Kayden, in 1984, showed that vitamin E 
uptake by fibroblasts occured via the high affinity 
LDL receptor, but could also be transported into the 
cells via a receptor-independent mechanism.
It is therefore possible that vitamin E could 
prevent LDL and ox-LDL uptake by directly competing 
for transport mechanisms.
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Viamin E was found to have similar effects in both 
WKY and SHRSP vascular smooth muscle cells.
Results therefore suggest that in the present study, 
any additional effects of genetic hypertension on 
cellular function in relation to cholesterol uptake, 
occurred via enhancement of, or similar mechanisms 
to, those observed in hypercholesterolemia (as both 
cell types were equally affected by vitamin E 
action).
Interestingly, 10 and IOOjoM concentrations of 
vitamin E also reduced basal free membrane 
cholesterol levels in a concentration-dependent 
manner.
Data by Thorin et al., 1995, found a negligible 
effect in bovine aortic endothelial cells.
Goldberg and Mendez, 1988, however, found that 
incubation of human skin fibroblasts with probucol
(2-5fjM) led to cholesterol efflux. In the presence 
of HDL, probucol caused an approximate 20% reduction 
in cell cholesterol content. This effect on
HDL-mediated cholesterol efflux was
concentration-dependent and was capable of producing
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a 2-fold increase in the amount of cholesterol 
leaving the cells.
Results from this study suggest that vitamin E may 
have similar non-antioxidant anti-atherogenic 
properties to probucol, and may explain why both 
these antioxidants have been particularly successful 
and consistent in preventing atherosclerotic 
development and progression in comparison to other 
antioxidants.
It is therefore possible that vitamin E may also 
reduce cholesterol overload and acculmulation 
through enhancement of cholesterol efflux from 
tissues.
The present study also examined the effects of the 
antioxidant NAC on LDL and ox-LDL mediated 
cholesterol uptake in WKY and SHRSP vascular smooth 
muscle cells.
NAC produced only a small attenuation of LDL and 
ox-LDL mediated effects in both cell types at the
higher (lOOfiM) concentration. At the lower (lOpM) 
concentration no effect was observed.
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Due to the action of NAC on both LDL and ox-LDL 
mediated cholesterol uptake effects of NAC cannot be 
attributable to its antioxidant properties alone, 
and sugggest another mechanism of action. It is 
possible that NAC may have a similar action to that 
previously described for vitamin E, whereby it 
prevents LDL and ox-LDL uptake by directly competing 
for transport mechanisms. Further work will be 
required to elucidate such mechanisms.
In the present study NAC did not alter basal free 
cholesterol content. This suggests that NAC does 
not, however, share all of vitamin Efs mechanisms of 
action.
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5
EFFECTS OF CELL STRETCH ON OX-LDL 
INDUCED MEMBRANE CHOLESTEROL 
ALTERATIONS IN CULTURED WKY VASCULAR 
SMOOTH MUSCLE CELLS
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5.1 INTRODUCTION
Increased awareness of vascular biology has led to a 
deeper understanding of the development and 
progression of atherosclerotic disease.
Foam cells are now known to be a result of LDL 
oxidation, and uptake by the scavenger receptors of 
monocytes/macrophages that have migrated into the 
intima. A prior requirement to this process appears 
to be the accumulation of plasma lipid in the intima 
of suceptible arteries.
The mechanisms of transport and distribution of 
these plasma macromolecules into the arterial wall 
is not fully understood, however, increased 
knowledge of the processes involved may contribute 
to the understanding of atherosclerotic disease.
Interest in blood flow and vascular hemodynamics 
have been motivated by a possible role in the uptake 
and accumulation of plasma lipid, and localization 
of early atherosclerotic lesions (Nerem et al., 
1993).
Hypertension is one of the most prevalent and most 
potent determinants of atherosclerotic disease.
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In particular, hypertension is a well known risk 
factor when associated with hypercholesterolemia 
(Hollander et al., 1976; Chobanian, 1983; McGill et
al., 1985; Kannel and Sytkowski, 1987; Chobanian et 
al., 1989).
The mechanisms by which hypertension contributes to 
atherosclerotic disease has not been established, 
however, since uptake of LDL is an important primary 
event in atherosclerosis it is possible that 
hypertension could accelerate the disease process by 
increasing cholesterol uptake by cells.
Several groups have examined the effect of
transmural pressure on low density lipoprotein 
transport with varying results.
Curmi et al., 1990, found that increased transmural 
pressure (from 7 0mmHg to 160mmHg) in the rabbit
thoracic aorta, caused a 44-fold increase in the
concentration of LDL in the inner layers of the 
arterial wall, and a much lower (10-fold) increase 
in the subsequent layers.
Similarly, Rosati and Garay in 1991 found that
turbulent flow stimulated cell uptake of exogenous 
cholesterol in rat aortic VSM cells.
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Cardona-Sanclemente and Born, 1996, discovered that 
accumulation of LDL by rat aorta was increased by
adrenaline or by angiotensin II at concentrations 
which raised blood pressure progressively and 
significantly. Previous work by this group (1994)
however, suggested that aortic accumulation of LDL 
was increased by angiotensin II even when pressor 
effects were small and transient, suggesting 
mechanisms independent of pressure.
Fry et al., 1992, however, found that normalized
transendothelial uptake of LDL across normal intact 
minipig aortic endothelial surfaces were insensitive 
to pressure, in a dual pressure/flow model.
Differing results may be due to the various
different cell preparations used, or a result of
variations in the methods and techniques used and 
the haemodynamic forces simulated.
In vivor cells are continuously exposed to forces 
existing within the vessel. Such forces can be 
resolved into 2 components
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1 Pressure
- acting perpendicular to the surface
2 Shear Stress
a tangential dragging component resulting from 
friction with the endothelial surface
The VSM cell constituent of the vessel wall absorbs 
most of the pressure, whereas the endothelium is 
subjected to the shear stress (Davies, 1989).
It is therefore practical to study the effects of 
these forces separately.
Cell culture experiments represent a model which 
allows the study of the specific mechanisms involved 
in biological responses, under well-defined 
mechanical conditions.
Stretch/pressure is a significant hemodynamic factor 
of blood pressure (particularly in hypertension). 
Limited studies have looked at the effects of 
pressure alone on the vascular system. These have 
been of a preliminary nature but have suggested that 
further investigations are warranted (Nerem et al., 
1993).
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5.2 AIMS
The aim of this study was to examine the effects of 
cell stretch on ox-LDL-induced cholesterol uptake in 
WKY VSM cells using a novel cell stretch apparatus.
5.3 METHODS
Cells were cultured, ox-LDL prepared, and
experimental protocols carried out as described 
previously (see 2.2.1-2.2.6).
Cells were grown on fibronectin-treated silicone 
sheeting mounted on a novel cell stretch apparatus 
developed by Deehan, 1994 (Fig. 5.1).
To mimic the pressure component in vitro the
apparatus was designed to expose cells to a
controlled uniform stretching force, resulting in an 
increase in the length of the cells.
On day 2 WKY VSM cells were either:-
1 carefully exposed to a stretch of 20%
2 allowed to remain at a control tension
Cells were then incubated for 24 hours in medium 199 
containing 20|ag/ml ox-LDL.
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Cell Stretch Apparatus
MOVING CLAMP 
TO ADJUST TENSION
TOP CLAMPS
FIXED CLAMP
HANDLE BY WHICH 
TENSION ADJUSTED
PERSPEX BASE AND COMPONENTS 
(EASILY CLEANED AND 
STERILISED)
SILICONE SHEETING ON WHICH CELLS GROWN
FIG. 5.1 — Sketch of cell stretch apparatus
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Following incubation cells were scraped from the 
silicone and free membrane cholesterol measured by 
enzymatic fluorescence assay determination. Protein 
content was measured using a modified Lowry assay.
5.4 DATA CALCULATION AND STATISTICS
Results were expressed in 1 \xg cholesterol per mg 
protein’ . The mean for each incubation group was 
calculated +/- standard error of the mean (SEMEAN).
Statistical analysis was carried out using a 
2-sample (paired) t test (differences being 
considered significant when p<0.05).
5.5 RESULTS
Ox-LDL-mediated cholesterol uptake was compared 
between WKY VSM cells which were incubated at a 
control tension and those which were exposed to a 
single uniform stretch of 20% (Fig. 5.2).
No significant difference in free cholesterol 
content was observed between control and 20% stretch
VSM cells following incubation with 20|ig/ml ox-LDL. 
Similar levels of ox-LDL-mediated cholesterol uptake 
were observed in both groups.
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Cholesterol Uptake -  3 Day Protocol
n=6
8 i
Cholesterol 
(jjg per mg protein)
No Stretch 20% Stretch
20jjg/ml ox-LDL
FIG. 5.2 - Effect of 20|4.g/ml ox-LDL +/- 20% cell stretch on 
free membrane cholesterol content in WKY cultured vascular 
smooth muscle cells
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5.6 DISCUSSION
In the present preliminary study, no significant 
difference was observed in ox-LDL-mediated 
cholesterol uptake by VSM cells exposed to a uniform 
stretch of 20%, compared to those incubated at a 
control tension.
Such results differ from that of Curmi et al., 1990
and Meyer et al., 1996, who have investigated the 
effects of pressure on cholesterol uptake and 
accumulation in the vessel wall. Both groups 
observed an increased uptake of LDL cholesterol with 
increasing pressure.
Studies by these groups were carried out using 
isolated aortic segments as opposed to cells in 
culture. Results may therefore differ due to the 
considerably different methods of pressure 
application and experimentation used.
Negative results obtained in the present study may 
also be due to a variety of reasons.
Initial experimental conditions were developed by 
Deehan, in 1994, for the use of rat mesenteric VSM 
cells with the cell stretch apparatus. These 
conditions, although modified, were not ideal for
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the growth of rat aortic VSM cells, however complete 
resetting of conditions was outwith the range of 
this Ph.D.
As previously mentioned, cells were grown on
fibronectin-coated silicone sheeting.
In 1995 Beppu et al., found that substrate-bound 
fibronectin enhanced the binding and uptake of
ox-LDL by macrophage scavenger receptors. Although 
VSM cells are not thought to express scavenger 
receptors under normal conditions, further 
investigation is required to ascertain fully the
effect of fibronectin on cholesterol uptake in this 
cell type.
Such investigation would be required to validate any 
results already achieved under the present 
conditions, and to substantiate methods before any 
further studies are carried out.
Also of interest in the future would be the adaption 
of stretch apparatus to expose cells to a pulsatile 
cell stretch. Cyclical stretch in preference to a 
single fixed stretch (as used in the present study), 
would allow examination of pressure effects under 
conditions nearer to those observed physiologically.
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Results from the present study are therefore 
inconclusive, however demonstrate a potential model 
for future investigations of hemodynamic forces on 
cellular function, in the absence of other humoral 
influences.
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6
EFFECTS OF NATIVE AND OXIDISED LDL ON 
VASCULAR REACTIVITY IN THE RAT AORTA
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6.1 INTRODUCTION
For years the arterial system was viewed as a static 
network of resistance vessels responsible for the 
maintenance of arterial pressure.
However, in the past 16 years the discovery of the 
ability of the vascular endothelium to regulate 
vascular tone via the production of contractile and 
relaxant factors, has revolutionised, and brought 
about a new understanding, of vascular biology.
Known contractile factors include endothelin, 
angiotensin II, and the cyclooxygenase pathway 
products thromboxane A2, prostaglandin H2, and 
superoxide, whereas relaxant factors identified to 
date include prostacyclin and nitric oxide (NO) 
(Luscher, 1993; Ross, 1993; Daugherty et al., 1995).
Of these factors NO has been extensively studied, 
and has proved to be of particular importance.
In 1980 Furchgott and Zawadzki demonstrated that 
acetylcholine-induced vasodilation in isolated 
preparations of rabbit aorta required intact 
endothelium, and resulted from the release of an 
endothelium-derived relaxing factor (EDRF), now 
known to be identical or similar to NO.
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NO has since been implicated in a wide range of 
physiological and pathophysiological actions from 
roles in nonspecific immunity and endotoxic shock, 
to actions as a neurotransmitter.
In the vasculature NO has numerous actions including 
preservation of endothelial permeability and 
integrity, regulation of VSM proliferation and 
leucocyte-vessel wall interactions, and provision of 
antithrombic activity (Loscalzo and Welch, 1995).
In particular NO is a primary determinant of resting 
vascular tone through basal release, and causes 
vasodilation in response to various vasodilator 
agents such as acetylcholine, bradykinin, substance 
P, and increases in flow and shear stress (Calver et 
al., 1993).
It is now thought that dysregulation of NO 
production/effect may contribute to the pathogenesis 
of a number of vascular disorders, including 
hypertension, reperfusion injury, and
atherosclerosis.
Alterations in vascular function are well documented 
in the development of atherosclerotic disease 
(Heistad et al., 1984; Berkenboom et al., 1987;
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Forstermann et al., 1988; Shimokawa and Vanhoutte,
1988) . Risk factors such as elevated cholesterol 
levels have been linked to these alterations, 
however exact mechanisms are not fully understood.
As a result of numerous investigations examining the 
effects of LDL cholesterol on vascular tone, it has 
become apparent that LDL exerts 2 main effects:-
1 LDL impairs endothelium-dependent relaxation
(Andrews et al., 1987; Jacobs et al., 1990; Kugiyama 
et al., 1990; Galle et al., 1991; Tanner et al.,
1991; Chin et al., 1992; Myers et al., 1994).
2 LDL alters reactivity of vascular smooth muscle to 
contractile agonists
(Broderick et al., 1989; Galle et al., 1990)
These vascular effects have been shown to be
primarily due to ox-LDL (although effects have been 
observed to a lesser extent on exposure to native 
LDL - Andrews et al., 1987; Jacobs et al., 1990;
Galle et al., 1991; Myers et al., 1994).
Dysfunction of the NO pathway is thought to account
for the impairment of stimulated NO release or
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endothelium-dependent relaxation by agonists such as 
acetylcholine ( NOTE - NO release has been used as a 
generalisation to cover NO action, which may be 
impaired at any point of the NO pathway).
More recently it has been suggested that 
modification of basal NO release may also occur, and 
may contribute to the changes in vascular reactivity 
observed. Few studies to date have examined this 
possibility.
6.2 AIMS
The aim of this study was to investigate the effects 
of native and oxidised LDL on vascular reactivity, 
in particular basal and stimulated NO release.
More specifically the aim of the present study was 
to examine the effects of native and oxidised LDL 
on: -
1 receptor-dependent contraction
2 receptor-independent contraction
3 stimulated NO release
4 basal NO release
5 VSM sensitivity to exogenous NO
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6.3 METHODS
LDL and ox-LDL were prepared, and experiments 
carried out, as previously described (see 2.2.3, 
2.2.7, 2.2.8).
Aortic rings 3-4mm wide were prepared from male 
Sprague Dawley rats (>6 weeks). Rings were incubated 
for 5 hours, at 37°C, 5% C02 95% air, in either Krebs
bicarbonate buffer (control) , 100|ig/ml, or 500^ig/ml
LDL or ox-LDL solutions. Experiments were also 
conducted using 20jj,g/ml ox-LDL.
Following incubation rings were mounted under lg 
tension for recording of isometric tension.
Cumulative concentration-response curves were 
constructed to phenylephrine (10"8-3xl0"5M) , carbachol 
( 10"8-3x10_5M) , SNP (10_11-10"7M) , and potassium 
chloride (10"2-10_1M) . Tissues were then contracted to 
the EC20 phenylephrine and the nitric oxide synthase
inhibitor L-NAME (200fiM) added at the plateau of 
phenylephrine contraction.
Following experimentation tissues were blotted dry 
and their wet weight taken.
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(Note - all experiments were
endothelium intact rings in
indomethacin, p-estradiol, and
otherwise stated ).
carried out in
the presence of
cocaine, unless
In seperate experiments with LDL 4pM final 
concentration EDTA and BHT were added to solutions 
immediately following incubation to prevent further 
oxidation. Levels of incubation-induced oxidation 
were measured using a modified TBA assay with 
appropriate ox-LDL and preincubation controls.
6.4 DATA CALCULATION AND STATISTICS
Data were calculated fg tension per O.lg tissue', and 
results expressed as mean +/- standard error of the 
mean (SEMEAN).
Statistical analysis was carried out using repeated 
measures ANOVA, and Bonferroni paired multiple
comparison tests (differences being considered 
significant when p<0.05).
6.5 RESULTS
6.5.1 EFFECTS OF LDL AND OX-LDL ON 
PHENYLEPHRINE-INDUCED CONTRACTION IN THE RAT AORTA
Effects of LDL and ox-LDL on receptor-mediated
contraction was investigated by examinination of
responses to the ax adrenoceptor agonist
phenylephrine.
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IOx-LDL treatment at both the 100ng/ml and 500ng/ml 
concentration had no significant effect on tissue 
sensitivity to phenylephrine (Fig. 6.1).
Similarly no alterations in phenylephrine 
concentration-response curve sensitivity was
observed following lOOfig/ml LDL treatment (Fig. 
6.2) .
Aortic rings incubated in 500|ig/ml LDL however, 
showed a decreased sensitivity to phenylephrine, and 
had significantly higher EC50 values than equivalent 
controls.
Maximum phenylephrine-induced contractions were 
significantly increased following incubation with
lOOjag/ml LDL and ox-LDL cholesterol (Fig.s 6.3, 6.4,
6.5, & 6.6). 500(ig/ml ox-LDL treated rings showed a
similar trend.
Interestingly, on incubation with 500|iig/ml LDL a 
significant decrease in maximum phenylephrine 
induced contraction was observed.
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RAT AORTA
Phenylephrine C o n c e n tra tio n -R e s p o n s e  C urve
100 n
. - I
80 -
■ Krebs Control 
A 100^g/m l OX-LDL 
▼ 500pg/m l OX-LDL
60 -
Response [X Max.!
40  -
n=11
20 -
10"9 10~8
Concentration (M)
FIG. 6.1 - Effect of ox-LDL (100 & 500|i.g/ml) on phenylephrine
concentration-response curve in the rat aorta.
RA T AO RTA
Phenylephrine C o n c e n tra t io n -R e s p o n s e  C urve
100 - |
80 -
■ Krebs Control 
a 100pg/m l LDL 
t 500pg/m l LDL
n=10
60 -
Response (X Max.) * EC50
40  -
20 -
10~9
Concentration (M)
FIG. 6.2 - Effect of LDL (100 & 500|j.g/ml) on phenylephrine
concentration-response curve in the rat aorta.
* significant difference from control (p<0.05)
Note - % Max. = percentage of maximum phenylephrine response
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RAT AORTA
Phenylephrine Concentration-Response Curve
70 - i
60 -
Response 50 - 
(g tension per 0.1g tissue) 
40 -
30 -
20 -
10 -
10"510"9 10" *
■ Krebs Control 
*  100pg/ml OX-LDL 
▼ 500pg/ml OX-LDL 
n=11
Concentration (M)
FIG. 6.3 - Effect of ox-LDL (100 & 500jj.g/ml) on phenylephrine 
concentration-response curve in the rat aorta.
RAT AORTA
Phenylephrine Concentration-Response Curve
70 n
60 -
Response 50 - 
(g tension per 0.1 g tissue) 
40  -
30 -
20 -
10 -
10"* 10"* 10"4
■ Krebs Control 
*  100pg/m l LDL 
t 500pg /m l LDL 
n=10
Concentration (M)
FIG. 6.4 - Effect of LDL (100 & 500 jrg/ml) on phenylephrine
concentration-response curve in the rat aorta.
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E f fe c t  of  o x - L D L  on PE Maximum C ontract ion
n=11
5 0 - i  *
PE Contraction 
(g tension per 0.1g tissue)
3 0  •
CO NTROL 1 0 0 jjg /m l 5 0 0 p g /m l
ox-LDL
FIG. 6.5 - Effect of ox-LDL (100 & 500|xg/ml) on maximum
phenylephrine-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
Effect of LDL on PE Maximum Contraction
n -1 0
6 0  -
PE Contraction 50 - 
(g tension per 0.1 g tissue)
4 0
1 0 0 p g /m lCO N TR O L 5 0 0 fjg /m l
FIG. 6.6 - Effect of LDL (100 & 500jig/ml) on maximum
phenylephrine-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
O significant difference from LDL sample set (p<0.05)
116
6.5.2 EFFECTS OF LDL AND OX-LDL ON 
GARBACHOL-MEDIATED ENDOTHELIUM-DEPENDENT RELAXATION
Effects of LDL and ox-LDL on stimulated nitric oxide 
release were investigated by examination of 
responses to the muscarinic receptor agonist 
carbachol.
100|ig/ml ox-LDL treatment had no significant effect 
on tissue sensitivity to carbachol (Fig. 6.7).
Incubation with 500|ig/ml ox-LDL however, was found 
to decrease tissue sensitivity to carbachol; treated 
tissues having significantly higher EC50 values 
compared with their equivalent controls.
On incubation of tissues with lOOjag/ml and 500jj,g/ml 
LDL cholesterol, results suggested a dose-dependent 
decrease in carbachol concentration-response curve 
sensitivity, however this did not reach significance 
(Fig. 6.8).
100|ig/ml ox-LDL treatment had no significant effect 
on maximum carbachol-induced relaxation (Fig. 6.9).
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RAT AORTA
Carbachol Concentration-Response Curve
■ Krebs Control 
*  100pg/m l OX-LDL  
t 500pg /m l OX-LDL
20
40
n = 1 0
Response (% relaxation] EC50
60
80
100
10“6
Concentration (M]
F I G .  6 . 7  - Effect of ox-LDL (100 & 500|ig/ml) on carbachol
concentration-response curve in the rat aorta.
* significant difference from control (p<0.05)
RAT AORTA
Carbachol C oncentra t ion-Response Curve
Krebs Control 
100pg /m l LDL 
500 p g /m l LDL
20
40
Response (% relaxation]
60
80
100
10"8 10"*
Concentration (M)
F I G .  6 . 8  - Effect of LDL (100 & 500jxg/ml) on carbachol 
concentration-response curve in the rat aorta.
118
Incubation with 500fig/ml ox-LDL, however, was found 
to significantly reduce the maximum relaxation 
obtained to carbachol.
On incubation of tissues with 100(ig/ml and 500|rg/ml 
LDL, results suggested a dose-dependent reduction in 
carbachol-induced maximum relaxation, reaching 
significance in tissues incubated with the higher
(500}ig/ml) concentration (Fig. 6.10).
6.5.3 EFFECTS OF LDL AND OX-LDL ON SNP-INDUCED 
RELAXATION IN THE RAT AORTA
Effects of LDL and ox-LDL on VSM sensitivity to 
exogenous NO were investigated by examination of 
responses to the NO donor compound SNP.
Ox-LDL treatment, resulted in a dose-dependent 
reduction in SNP concentration-response curve
sensitivity; both 100|j,g/ml and 500(ig/ml ox-LDL 
treated tissues having significantly higher EC50 
values compared with their equivalent controls (Fig. 
6.11) .
On incubation of tissues with lOOjig/ml and 500fig/ml 
LDL, no significant effect on tissue sensitivity to 
SNP was observed (Fig. 6.12).
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E f fe c t  o f  o x - L D L  on C arbachol Maximum Relaxat io n
n=10
Response 
(X relaxation)
C O NTR O L lO O pg /m l 5 0 0 p g /m l
ox-LDL
FIG. 6.9 - Effect of ox-LDL (100 & 500fxg/ml) on maximum
carbachol-induced relaxation in the rat aorta.
* significant difference from control (p<0.05)
Effect of LDL on Carbachol Maximum Relaxation
n=8
100
6 0
Response 
(X relaxation)
4 0
CONTROL 1 00 p g /m l
LDL
5 0 0 p g /m l
FIG. 6.10 - Effect of LDL (100 & 500fxg/ml) on maximum
carbachol-induced relaxation in the rat aorta.
* significant difference from control
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RAT AORTA
SNP C oncentration-R esponse Curve
20 ■ Krebs Control 
a 100pg /m l O X-LD L  
▼ 500pg /m l O X-LD L
n=5
4 0
Response [X relaxation) * EC50
60
80
100
10“®10"“
Concentration (Ml
F I G .  6 . 1 1  - Effect of ox-LDL (100 & 500fj.g/ml) on SNP
concentration-response curve in the rat aorta.
* significant difference from control (p<0.05)
RAT A O R TA
SNP C o n c e n tra t io n -R e s p o n s e  C urve
20 -
■  Krebs C ontro l 
a 1 0 0 p g /m l LDL 
▼ 5 0 0 p g /m l LDL
n=6
4 0  -
Response (% relaxation)
6 0  -
8 0  -
100
10“8
Concentration  (M)
F I G .  6 . 1 2  - Effect of LDL (100 & 500ng/ml) on SNP
concentration-response curve in the rat aorta.
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LDL and ox-LDL had no significant effect on maximum 
SNP-induced relaxation; 100% relaxation being 
acheived in all ring preparations.
6.5.4 EFFECTS OF LDL AND OX-LDL ON L-NAME-INDUCED 
CONTRACTION IN THE RAT AORTA
Effects of LDL and ox-LDL on basal NO release were 
investigated by examination of contractile responses 
following exposure to the nitric oxide synthase 
inhibitor L-NAME (NOTE- contraction obtained 
following L-NAME treatment was taken as 
representative of basal NO release).
Incubation of tissues with 100p,g/ml and 500(j.g/ml 
ox-LDL resulted in a significant dose-dependent 
reduction in contraction following exposure to 
L-NAME (Fig. 6.13).
100|ig/ml and 500|ag/ml LDL treated tissues showed a 
similar trend, reaching significance at the higher 
500|ag/ml concentration (Fig. 6.14).
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E f f e c t  o f  o x - L D L  on L - N A M E  Respo nse
n=6
350 -i
300  -
Contraction 200 
(As a X of 1 0 -1 M KCI response)
150
CONTROL lOOpg/ml 500pg/m l
ox-LDL
FIG. 6.13 - Effect of ox-LDL (100 & 500|j,g/ml) on
L-NAME-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
** significant difference from control (p<0.01)
Effect of LDL on L-NAME Response
n=6
200 -1
Contraction 150 - 
(As a X of 10 -1 M  KCi response)
CONTROL 100pg/m l 500fjg /m l
LDL
FIG. 6.14 - Effect of LDL (100 & 500fxg/ml) on L-NAME-induced 
contraction in the rat aorta.
* significant difference from control (p<0.05)
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6.5.5 EFFECTS OF LDL AND OX-LDL ON POTASSIUM 
CHLORIDE MEDIATED CONTRACTION IN THE RAT AORTA
Effects of LDL and ox-LDL on receptor-independent 
contraction were investigated by examination of 
responses to potassium chloride (KCI).
LDL and ox-LDL treatment had no effect on tissue 
sensitivity to KCI (Fig.s 6.15 & 6.16).
Results suggested that 100|ig/ml and 500|j,g/ml ox-LDL 
treatment caused a slight increase in the maximum 
contraction obtained as a result of 10_1M KCI, 
however, this did not reach significance (Fig. 
6.17) .
100(j,g/ml LDL caused a significant increase in
maximum KCl-induced contraction, whereas 500|ig/ml 
LDL had no significant effect (Fig. 6.18).
6.5.6 EFFECTS OF 20ng/ml OX-LDL ON VASCULAR 
REACTIVITY IN THE RAT AORTA
Initial experiments were also carried out using a 
20}j,g/ml concentration of ox-LDL.
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RAT AORTA
KCI C o n c e n tra tio n -R e s p o n s e  C urve
100 - i
8 0  -
■ Krebs Control 
a 1 0 0 p g /m l O X -L D L  
▼ 5 0 0 p g /m l O X -L D L
60  -
Response (X Max
4 0  -
n = 1 1
20 -
0.10.01
Concentration (M)
F I G .  6 . 1 5  - Effect of ox-LDL (100 & 500(j.g/ml) on potassium
chloride concentration-response curve in the rat aorta.
RA T AO RTA
KCI C o n c e n tra t io n -R e s p o n s e  C urve
100 “ |
80  -
■  Krebs Contro l 
A 1 0 0 p g /m l LDL 
▼ 5 0 0 p g /m l LDL
60  -
Response (X Max.]
4 0  -
n=8
20 -
0.01 0.1
Concentration (M)
F I G .  6 . 1 6  — Effect of LDL (100 & 500jig/ml) on potassium
chloride concentration response curve in the rat aorta.
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Effect of ox-LDL on KCI Maximum Contraction
n=11
30 -i
Contraction 20 
(g tension per 0.1g tissue)
100jig /m l
ox-LDL
500Mg/m lCONTROL
FIG. 6.17 - Effect of ox-LDL (100 & 500|ig/ml) on maximum
potassium chloride induced contraction in the rat aorta.
Effect of LDL on KCI Maximum Contraction
n -8
40  -
Contraction 30 
(g tension per 0.1g tissue)
C O N TR O L 100pg/m l
LDL
500pg/m l
FIG. 6.18 - Effect of LDL (100 & 500jxg/ml) on maximum
potassium chloride induced contraction in the rat aorta.
* significant difference from control
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No effect on vascular reactivity was observed 
following tissue exposure to this concentration 
(results not shown).
6.5.7 EFFECT OF 5 HOUR INCUBATION ON LDL OXIDATION
Lipid peroxidation of native LDL was examined 
following 5 hours incubation to ascertain whether 
the standard incubation procedure used in the 
present study would cause a significant increase in 
oxidative modification.
Incubation of LDL for 5 hours under standard 
incubation conditions (see 6.3), resulted in only a 
small increase in oxidative modification which was 
not significant (oxidative modification as a 1 % of
500(j,g/ml ox-LDL response1 - preincubation control 
0.98%, LDL 1.54%; postincubation control 0.74%, LDL 
3.42%) (Fig. 6.19).
6.6 DISCUSSION
The aim of the present study was to investigate 
cholesterol-induced alterations of vascular function 
in vitro, by exposure of rat aortic ring 
preparations to LDL and ox-LDL.
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LDL OXIDATION
n=4
Oxidation
(As a % of 5 0 0 jjg /m l  
o x -L D L  response)
CONTRO L LDL
Preincubation
CO NTRO L LDL
Postincubation
FIG. 6.19 - Effect of 5 hour incubation on LDL oxidati on
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6.6.1 LDL AND OX-LDL EFFECTS ON RECEPTOR-DEPENDENT 
CONTRACTION
LDL and ox-LDL cholesterol (excluding 500jig/ml LDL) , 
caused a significant increase in maximum 
receptor-dependent contraction to phenylephrine, but 
had no effect on tissue sensitivity.
Similarly, Galle et al., 1990, observed augmented 
contractile responses in tissues perfused with 
ox-LDL in the presence of low concentrations of 
receptor-dependent contractile agonists.
Galle et al., however, found that ox-LDL (80fj,g/ml) 
also increased tissue sensitivity to the agonists 
norephinephrine and phenylephrine, and LDL had no 
effect on either maximal responses or tissue 
sensitivity.
Reasons for such discordance in results may be the 
considerable difference in experimental procedures 
used.
Galle et al. examined responses immediately 
following exposure, and in the presence of, 
ox-LDL/LDL. As a result experimentation by this
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method would measure acute effects only. Results may 
therefore be attributable to the agonist effects 
which are known to occur on LDL and ox-LDL exposure 
(Simon et al., 1990; Murohara et al., 1994).
In the present study, ring preparations were 
incubated for 5 hours in the presence of LDL/ox-LDL. 
Following incubation extracellular LDL/ox-LDL was 
removed and tissues allowed to equilibrate for an 
hour prior to examination of responses.
The present study was therefore designed to examine 
the chronic effects of LDL and ox-LDL on vascular 
function, and excluded any possiblility of acute 
agonist effects.
Interestingly, 500)^ g/ml LDL caused a decrease in 
sensitivity of aortic ring preparations to 
phenylephrine, and significantly reduced the maximum 
receptor-dependent contractions achieved.
Reasons for this LDL-specific effect could not be 
explained, however this did not appear to be due to 
tissue toxicity, as potassium chloride responses 
remained unaffected.
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6.6.2 LDL AND OX-LDL EFFECTS ON STIMULATED NO 
RELEASE
500|ng/inl ox-LDL reduced tissue sensitivity to 
carbachol, and caused a decrease in the maximum 
relaxation observed. Incubation with LDL cholesterol 
showed a similar trend.
These results substantiate those of numerous groups 
who found that ox-LDL (and to a lesser extent LDL) , 
attenuated stimulated NO release (Jacobs et al., 
1990; Simon et al., 1990; Andrews et al., 1987).
6.6.3 LDL AND OX-LDL EFFECTS ON VASCULAR SMOOTH 
MUSCLE SENSITIVITY TO EXOGENOUS NO
Ox-LDL (but not LDL), caused a dose-dependent 
reduction in tissue sensitivity to the NO donor SNP, 
although maximum relaxation was still achieved.
This substantiates the results of Jacobs et al., 
1990, who found that ox-LDL (but not LDL), evoked a 
small but significant rightward shift in the dose 
response curve to the NO donor glyceryl trinitrate.
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SNP is known to act as an nitric oxide donor, and 
therefore directly acts on the vascular smooth 
muscle to stimulate a relaxation effect.
The data from the present study suggests that ox-LDL 
can affect the relaxation pathway after NO synthesis 
and release, but provided weak evidence that
ox-LDL-induced dysfunction is at least partially due 
to free radical neutralisation of the NO molecule 
(Ohara et al., 1993, 1995; Pritchard et al., 1995).
6.6.4 LDL AND OX-LDL EFFECTS ON BASAL NO RELEASE
In the present study L-NAME contraction was studied 
as a measurement of basal NO release and was found 
to be the most sensitive system to dysfunction.
Incubation of tissues with ox-LDL resulted in a 
significant dose-dependent reduction in
L-NAME-mediated contraction, with a similar trend 
being observed following LDL treatment.
Attenuation of basal NO release by LDL and ox-LDL 
may account for the increased responses to 
phenylephrine observed, and potentiation of agonist 
responses reported during the early development of 
atherosclerotic disease (Kolodgie et al., 1990).
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In the present study basal release was shown to be 
more sensitive to LDL and ox-LDL, than 
carbachol-stimulated release, consistent with 
suggestions that alterations in contractile 
responses precede decreased endothelium-dependent 
relaxation in the atherosclerotic disease process.
Interestingly, Mian and Martin, 1995, recently found 
that basal NO activity was more sensitive to 
superoxide anion inactivation than
acetylcholine-stimulated activity.
Along with results from the present study this would 
also suggest 'free radical neutralisation' as a 
possible mechanism of ox-LDL action.
6.6.5 LDL AND OX-LDL EFFECTS ON RECEPTOR-INDEPENDENT 
CONTRACTION
Results from the present study have shown that 
100|4,g/ml LDL treatment causes a significant increase 
in the maximum KCl-induced contraction observed. 
100jig/ml and 500^g/ml ox-LDL treatment 1 showed a
similar trend, while 500ng/ml LDL had no significant 
effect.
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Incubation with ox-LDL and LDL did not alter tissue 
sensitivity.
As previously mentioned (see 3.1), it has been 
suggested that cholesterol may cause dysfunction 
effects by altering the cell membrane at the level 
of membrane physicochemical structure. Increased 
cell cholesterol content is known to decrease 
membrane fluidity, which in turn may alter membrane 
proteins leading to a modification of function. It 
is therefore possible that alterations in 
KCl-mediated contractions may be due to modification 
of ion channel sensitivity.
No alteration was observed following incubation with
the higher (500(o,g/ml) LDL concentration, however 
this LDL concentration was found to have unique 
effects on other aspects of contractile reactivity 
as mentioned previously (see 6.6.1).
6.6.6 EFFECT OF 5 HOUR INCUBATION ON LDL OXIDATION
Incubation of LDL for 5 hours under standard 
incubation conditions had no significant effect on 
the level of oxidative modification of native LDL.
LDL effects observed in the present study are 
therefore, not attributable to oxidative
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modification occuring during the incubation 
procedure.
Caution must however, be taken when interpreting 
data as although TBARS are a commonly used 
laboratory technique for the measurement of lipid 
peroxidation levels, the LDL particle may have 
undergone numerous stages of oxidative damage, while 
still being outwith the peroxidation levels required 
for measurement.
Such partially oxidised or 'minimally modified' LDL 
has been shown to have various effects, as seen with 
fully oxidised LDL (Witztum and Steinberg, 1991; 
Parhami et al., 1995) .
It is likely that much of the controversy 
surrounding LDL effects, and variation in results, 
is due to such minimal oxidative modification which 
will vary in degree depending on experimental 
procedures.
6.6.7 GENERAL DISCUSSION
The following study has therefore shown that both 
LDL and ox-LDL effect numerous aspects of vascular 
reactivity in vitro.
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In summary 
Ox-LDL
1 Maximum phenylephrine induced contractions were significantly 
increased following incubation with ox-LDL
2 ox-LDL significantly reduced tissue sensitivity to carbachol, 
and maximum relaxation obtained
3 Ox-LDL treatment resulted in a significant dose-dependent
reduction in SNP concentration-response curve sensitivity
4 Ox-LDL treatment resulted in a significant dose-dependent
reduction in L-NAME-induced contraction
5 Results suggested that ox-LDL caused a small increase in 
maximum potassium chloride induced contraction (however this 
was not significant)
LDL
1 LDL significantly reduced tissue sensitivity to phenylephrine
2 Maximum phenylephrine-induced contraction was significantly
increased following incubation with low concentration LDL, 
whereas higher concentration LDL treatment caused a significant 
reduction in response
3 Results suggested that LDL caused a dose-dependent reduction 
in carbachol concentration-response curve sensitivity (although 
did not reach significance) , and a similar reduction in the 
maximum carbachol-induced relaxation obtained
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4 Results suggested that LDL treatment caused a dose dependent 
reduction in L-NAME-induced contraction
5 Low concentration LDL treatment caused a significant increase 
in maximum potassium chloride induced contraction
Further studies using human arterial preparations 
would be of much interest in the future, 
particularly with regards to the effects of LDL 
cholesterol on basal and stimulated NO pathways.
The activity of both these pathways has been shown 
to vary considerably between species, and also 
intraspecies, between arteries (Christie and Lewis, 
1991; Christie et al., 1989).
Studies examining effects within the human arterial 
system will therefore prove vital in substantiating 
the results of previous animal models.
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7
INVESTIGATION INTO MECHANISMS 
UNDERLYING LDL AND OX-LDL EFFECTS
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7.1 INTRODUCTION
As previously mentioned, LDL cholesterol exerts two 
main effects on vascular reactivity:-
1 LDL impairs endothelium-dependent relaxation
(Andrews et al., 1987; Jacobs et al., 1990; Kugiyama 
et al., 1990; Galle et al., 1991; Tanner et al., 
1991; Chin et al., 1992; Myers et al., 1994).
2 LDL alters reactivity of vascular smooth muscle to 
contractile agonists
(Broderick et al., 1990; Galle et al., 1990).
Knowledge of this impairment of
endothelium-dependent vasodilation and augmentation 
of contractile responses, has led to a focus of 
interest on the possible link between lipoproteins 
and impaired synthesis/effect of NO.
Indeed, in chapter 6, ox-LDL (and to a lesser extent 
LDL) was found to affect both basal and stimulated 
NO release. Ox-LDL also attenuated tissue 
sensitivity to the exogenous NO donor SNP.
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Although impairment of NO function is known to take 
place the mechanisms by which this dysfunction 
occurs remain controversial.
7.1.1 NITRIC OXIDE SYNTHASE INHIBITION
In recent years a limited number of studies have 
suggested that low-density lipoproteins affect 
vascular reactivity by inhibiting the enzyme nitric 
oxide synthase (NOS).
In 1995 Liao et al., found that ox-LDL decreased the 
expression of endothelial NOS (eNOS) in human 
saphenous vein endothelial cells. This was thought 
to be through a combination of early transcriptional 
inhibition and post-transcriptional mRNA
destabilisation.
Yang et al., 1994, found that on examination of
iNOS activity in an activated macrophage cell line, 
inducible NOS (iNOS) could also be inhibited by 
ox-LDL.
Such results indicate a potential mechanism for LDL 
and ox-LDL induced NO dysfunction via alteration of 
NOS activity.
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Due to the massive accumulation of cholesterol 
unique to macrophages, and differences in the NO 
pathway and activity between the venous and 
arterial system (Thorin-Trescases et al., 1995), 
these studies only provide limited knowledge of 
possible LDL and ox-LDL mechanisms in 
arteriovascular dysfunction. Further investigation 
using arterial preparations are now required to 
elucidate LDL and ox-LDL effects on arterial eNOS 
and iNOS activity.
7.1.1.1 The Glucocorticoids
Since as early as 1969, glucocorticoids have been 
known to potentiate vasoconstrictor responses to 
contractile agonists in animal models (Kalsner, 
1969; Yard and Kadowitz, 1972).
In recent years it has been discovered that 
glucocorticoids, such as dexamethasone exert their 
action by inhibition of expression of inducible, but 
not constitutive, NOS (Rees et al., 1990; Radomski
et al.f 1990; Pfeilschifter, 1991; Baydoun et al., 
1993) .
Glucocorticoids therefore provide an ideal tool for 
the study of iNOS and eNOS activity in isolated 
tissue preparations.
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7.1.2 FREE RADICAL NEUTRALISATION
Another theory rapidly accumulating interest is that 
of 'free radical neutralisation'. An increasing 
number of studies have provided evidence to indicate 
that ox-LDL induced NO dysfunction may, at least 
partially, be due to free radical neutralisation of 
the NO molecule.
In 1990, Galle et al., suggested that ox-LDL 
enhanced agonist-induced vasoconstrictions by a 
direct effect on the vascular smooth muscle. This 
group was later to suggest that both LDL and ox-LDL 
inhibited endothelium-dependent vasodilation by 
inactivating NO released from the endothelial cells 
(Galle et al., 1991).
Around the same time, Jacobs et al., 1990, 
discovered that both LDL and ox-LDL reversibly 
inhibited relaxations evoked by exogenous NO in 
rabbit aorta. Ox-LDL (but not LDL), also reversibly 
inhibited relaxations evoked by the NO donor 
compound glyceryl trinitrate.
Initial studies such as those above, therefore 
suggested that LDL and ox-LDL could effect the NO 
pathway at a point following endothelial release, 
and several investigators began to focus on the
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possibility that NO was being inactivated after 
release, and prior to vascular smooth muscle 
stimulation.
7.1.2.1 The Superoxide Anion
The inactivation of EDRF by superoxide anion was 
recognised before the demonstration that EDRF was NO 
in 1987 (Wei et al., 1985; Palmer et al., 1987; 
Marin and Rodriguez-Martinez, 1995).
Suggestions that NO was being inactivated following 
release and possibly prior to smooth muscle 
activation therefore led to the development of a 
'free radical neutralisation' hypothesis in which 
the superoxide anion was the 'potential culprit'.
Dowell et al., 1993, discovered that exposure of 
rabbit aortic ring preparations to superoxide anions 
and hydroxyl radicals (via a xanthine 
oxidase/hypoxanthine generating system) caused 
impairment of endothelium-dependent carbachol 
induced relaxation. Similar results were observed by 
Furchgott et al. (19941, 19942) .
Ohara et al., 1993, demonstrated that an excess 
generation of superoxide anions occurred within 
hypercholesterolemic vessels, from cholesterol fed
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New Zealand white rabbits. Dietary correction of 
hypercholesterolemia improved endothelium-dependent 
vascular relaxation, and normalised endothelial 
superoxide anion production.
More recently, Araujo et al., 1995, found that 
reactive oxygen species production by leucocytes was 
positively correlated with elevated VLDL or LDL 
levels in clinical studies, and in the same year, 
Pritchard et al., 1995, found that native LDL
increased endothelial NOS generation of the
superoxide anion in cultured human umbilical vein 
endothelial cells.
Finally, Mian and Martin, 1995, found that basal NO 
activity was more sensitive to superoxide anion 
inactivation than acetylcholine-stimulated activity. 
This is similar to the observations in chapter 6, 
whereby basal NO release was shown to be more 
sensitive to LDL and ox-LDL, than carbachol 
stimulated release.
Recent results, therefore suggest that LDL and 
ox-LDL induced NO dysfunction may occur as a result 
of enhanced superoxide anion generation, resulting 
in an increased inactivation of the NO molecule.
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Interestingly, in vivo superoxide may act as a 
precursor for the formation of numerous other free 
radical species, and several groups have suggested 
that it may be the resultant radicals such as 
hydrogen peroxide and peroxinitrite (+ resultant 
hydroxyl radicals) , that act as the primary 
cytotoxic reactive species (Link and Riley, 1988; 
Beckman et al,, 1990; Beckman and Tsai, 1994; 
Darley-Usmar and Radomski, 1994; Harrison and Ohara, 
1995).
7.1.2.2 Antioxidant Protection
Indication of a potential mechanism for LDL and 
ox-LDL induced NO dysfunction via inactivation of 
the NO molecule by free radical neutralisation, has 
stimulated interest in the possibility of additional 
benefits of antioxidants not previously realised.
If true, this would suggest a 2nd site of action at 
which antioxidants could protect against the 
atherosclerotic effects of low-density lipoproteins.
Antioxidants, such as vitamin E, could not only 
prevent oxidative modification of LDL into its more 
potent atherogenic form, but could also reduce NO 
dysfunction by protecting against free radical 
neutralisation of the NO molecule.
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Investigation into the effect of vitamin E on LDL 
and ox-LDL induced alterations of vascular 
reactivity, would therefore be of much interest.
7.1.2.3 Superoxide Dismutase
All cells in eukaryotic organisms contain powerful 
antioxidant defense systems against free radicals. 
If it were not for these protective antioxidant 
defenses generation of free radical chain reactions 
would quickly cripple and destroy cellular functions 
(Sies, 1993).
Within the human body the natural antioxidant 
defense systems include catalase, glutathione
peroxidase, and superoxide dismutase (SOD).
SOD is a large water soluble molecule, which
provides the main line of defence against the 
superoxide anion. As a preventive antioxidant, SOD 
rapidly converts superoxide anion to hydrogen
peroxide, which may then be scavenged by catalase 
(DeBono, 1994) .
Three isoforms of SOD are known to exist; 
Mitochondrial Mn-SOD, intracellular (or cytosolic) 
CuZn-SOD, and extracellular (or secreted) CuZn-SOD.
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In 1995 Stralin et al., noted that human blood 
vessel walls (particularly those of arteries), 
contained exceptionally large amounts of 
extracellular SOD, indicating the probable 
importance of this extracellular enzyme.
Since studies have suggested that superoxide anion 
is responsible for LDL/ox-LDL induced NO 
dysfunction, investigation into the effects of 
extracellular SOD on LDL and ox-LDL mediated 
alterations of vascular reactivity would be of great 
interest.
7.2 AIMS
The aim of the present study was to investigate 
possible mechanisms underlying LDL and ox-LDL 
effects on vascular reactivity in the rat aorta.
More specifically the aim of the present study was 
to examine:-
1 Basal iNOS and eNOS activity (and the effect of 5 
hour incubation on)
2 The effect of LDL and ox-LDL on iNOS and eNOS 
activity
3 The effect of vitamin E on LDL-induced alterations 
of vascular reactivity
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4 The effect of SOD on LDL and ox-LDL induced 
alterations of vascular reactivity
7.3 METHODS
LDL and ox-LDL were prepared, and experimental 
protocols carried out, as previously described (see 
2.2.3, 2.2.7, 2.2.8).
Aortic rings 3-4mm wide were prepared from male 
Sprague Dawley rats (>6 weeks).
7.3.1 DEXAMETHASONE EXPERIMENTS
Rings were either immediately mounted under lg 
tension for recording of isometric tension (-inc.) 
or incubated for 5 hours, at 37°C, 5%C02 95% air, in
either vehicle control or 500|ig/ml LDL/ox-LDL ( + /-
0. 5|aM dexamethasone (dex.)) ( + inc.). All experiments 
were carried out in the presence (+E) or absence 
(-E) of endothelium.
Tissues were checked for endothelial integrity (by 
examination of carbachol response following 
preconstriction with EC70 phenylephrine), and 
cumulative concentration-response curves constructed 
to phenylephrine (10"8-3xl0_5M) and potassium chloride 
(10"2-10_1M) . Tissues were then contracted to the EC20
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phenylephrine and the nitric oxide synthase
inhibitor L-NAME (200|aM) added at the plateau of 
phenylephrine contraction.
7.3.2 VITAMIN E EXPERIMENTS
Rings were incubated for 5 hours, at 37°C, 5% C02 95% 
air, in either control or 500|o,g/ml LDL cholesterol
( + /- lOOjiM vitamin E) . Following incubation rings 
were mounted under lg tension for recording of 
isometric tension.
Cumulative concentration-response curves were 
constructed to phenylephrine (10_8-3xl0_5M) , carbachol 
( 10"8-3x 10_5M) , SNP (10"n-10"7M) , and potassium
chloride (10“2-10_1M) . Tissues were then contracted to 
the EC20 phenylephrine and the nitric oxide synthase
inhibitor L-NAME (200|jM) added at the plateau of 
phenylephrine contraction.
In separate experiments with vitamin E 4|uM final 
concentration EDTA and BHT was added to solutions 
immediately following incubation to prevent further 
oxidation. Levels of incubation-induced oxidation 
were measured using a modified TBA assay with
appropriate vitamin E, ox-LDL, and preincubation 
controls.
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7.3.3 SUPEROXIDE DISMUTASE EXPERIMENTS
Rings were incubated for 5 hours, at 37°C, 5% C02 95%
air, in either vehicle control, or 500|ng/ml 
LDL/ox-LDL (+/- 45 units/ml SOD). Following
incubation rings were mounted under lg tension for 
the recording of isometric tension.
Cumulative concentration-response curves were 
constructed to phenylephrine (10"8-3xl0_5M) , carbachol 
( 10“8-3x 10”5M) , SNP (10_11-10_7M) , and potassium 
chloride (10~2-10_1M) . Tissues were then contracted to 
the EC20 phenylephrine and the nitric oxide synthase
inhibitor L-NAME (200|iM) added at the plateau of 
phenylephrine contraction.
Following experimentation all tissues were blotted 
dry and their wet weight taken.
7.4 DATA CALCULATION AND STATISTICS
Data were calculated 'per O.lg tisssue' and results 
expressed as mean +/- standard error of the mean.
Statistical analysis was carried out using repeated 
measures ANOVA, and Bonferroni paired multiple 
comparison tests (differences being considered 
significant when p<0.05).
150
7.5 RESULTS
7.5.1 RESULTS FROM DEXAMETHASONE EXPERIMENTS
As previously described, basal NO release was 
investigated by examination of contractile responses 
following exposure to the nitric oxide synthase 
inhibitor L-NAME.
7.5.1.1 Preincubation L-NAME Responses +/- 
Endothelium
L-NAME induced-contraction was examined in aortic 
ring preparations with and without endothelium, 
immediately following removal from the animal, and 
prior to incubation.
On removal of the endothelium L-NAME-induced 
contraction was significantly reduced (>70%)(Fig. 
7.1) .
7.5.1.2 Effect of 5 Hour Incubation +/- 
Dexamethasone on L-NAME Responses in the Rat Aorta
The effect of 5 hour incubation on L-NAME-induced
contraction in the presence and absence of 0. 5|jM 
dexamethasone was examined in both endothelium 
intact and endothelium denuded ring preparations.
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L - N A M E  R espo nse  + / -  E ndothelium  
n = 6
100
Contraction  
(As a % of 1 0 -1 M  KCI response)
-inc . - in c ./ -E
FIG. 7.1 - L-NAME-induced contraction in preincubation rat
aortic ring preparations +/- endothelium.
* significant difference from control (p<0.05)
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In endothelium intact rings, there was some 
indication that 5 hour incubation caused a small 
increase in L-NAME-induced contraction, however this 
did not reach statistical significance (Fig. 7.2).
Dexamethasone appeared to abolish any
incubation-mediated induction of L-NAME response.
In endothelium denuded tissues, induction was 
considerably greater; 5 hour incubation resulting in 
a significant increase in L-NAME-induced contraction 
(Fig. 7.3).
Incubation-mediated induction of L-NAME responses 
was blocked by the presence of dexamethasone.
7.5.1.3 Effect of Dexamethasone on L-NAME Response 
+/- LDL and Ox-LDL
The effect of 0. 5|iM dexamethasone on L-NAME-induced 
contraction was examined in the presence and absence 
of 500(ig/ml LDL and ox-LDL.
Results suggested that incubation with both LDL and 
dexamethasone reduced L-NAME-induced contraction to 
a similar degree as incubation with dexamethasone 
alone (p=0.0511)(Fig. 7.4).
T53
E ffect of Dexamethasone (0.5pM) on L -N A M E  Response
Endothelium Intact 
n=6
Contraction 80
(As a % of 10-1M  KCI Response)
F I G .  7 . 2  - Effect of 5 hour incubation on L-NAME-induced
contraction +/- 0.5|JM dexamethasone in the rat aorta
(endothelium intact).
E ffec t of Dexamethasone (0.5pM) on L -N A M E  Response
No Endothelium 
n=6
120 
100
Contraction
(As a % of 10-1M  KCI Response)
-inc. +inc. +inc./dex.
F I G .  7 . 3  - Effect of 5 hour incubation on L-NAME-induced
contraction +/- 0. 5|iM dexamethasone in the rat aorta
(endothelium denuded).
* significant difference from control (p<0.05)
O significant difference from+inc. sample group (p<0.05)
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Effect of Dexamethasone (0.5pM) on 
L-NAME Response to 500yg /m l LDL
Endothelium Intact 
n=6
C ontraction  150
(As a % of 1 0 -1 M  KCI Response)
CO N TR O L DEX. LD L/D EX .
F I G .  7 . 4  - Effect of dexamethasone (0.5(aM) on L-NAME response 
+/- 500|ig/ml LDL (endothelium intact) .
Effect of Dexamethasone (0 .5 |jM) on 
L-N A M E  Response to 5 0 0 ^ g /m l O x-LD L
Endothelium In tact
C o n tra c tio n  15 0
(As a % o f 1 0 -1 M  KCI Response)
C O N T R O L  DEX. O X /D E X .
F I G .  7 . 5  - Effect of dexamethasone (0.5nM) on L-NAME response 
+/- 500(j.g/ml ox-LDL (endothelium intact) .
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Ox-LDL treated tissues showed a similar pattern, 
with a trend towards lower responses when incubation 
included both ox-LDL and dexamethasone compared with 
dexamethasone alone (p=0.0597)(Fig. 7.5).
7.5.2 RESULTS FROM VITAMIN E EXPERIMENTS
Effects of 500(j,g/ml LDL +/- lOOjjM vitamin E on 
vascular reactivity was examined in the rat aorta.
7.5.2.1 Effect of LDL +/- Vitamin E on
Phenylephrine-induced Contraction in the Rat Aorta
The effect of LDL +/- vitamin E on receptor-mediated
contraction was investigated by examination of
tissue responses to the (Xj adrenoceptor agonist
phenylephrine.
As previously, results suggested a small decrease in 
sensitivity to phenylephrine following incubation
with 500(ig/ml LDL (although in the present study 
this did not reach significance)(Fig.7.6).
Vitamin E appeared to have no effect on this 
LDL-induced decrease in phenylephrine sensitivity.
Incubation with LDL significantly reduced maximum 
phenylephrine-induced contraction (Fig.s 7.7 & 7.8).
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RA T A O R T A
Phenylephrine C o n c e n tra tio n -R e s p o n s e  C urve
100 -1
80  -
■  Krebs Contro l 
*  Vitamin E (1 0 0 jiM )  
r  5 0 0 p g /m l LDL 
O L D L /V it. E
n=9
6 0  -
Response (% Max.!
4 0  -
20 -
10 '8
Concentration  (M)
F I G .  7 . 6  - Effect of LDL (500fig/ml) +/- lOOfoM vitamin E on
phenylephrine concentration-response curve in the rat aorta.
NOTE - vitamin E curve cannot be seen as coincides, and falls 
directly beneath, Krebs control curve
Note % Max. percentage of maximum phenylephrine response
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RAT AORTA
Phenylephrine Coneentration-Response Curve
70 1 
60 -
Response 50 - 
(g tension per 0.1 g tissue)
40 -
30 -
20 -
10 -
0 HP 1 ■' I ITiT 1 ....1..  I......     1  1
1 0 '“ 10"* 10"7 10-6 1Cf5 10"4
Concentration (M)
FIG. 7.7 - Effect of LDL (500}xg/ml) +/- 100}iM vitamin E 
phenylephrine concentration-response curve in the rat aorta.
Effect of LDL on PE Maximum Contraction + / -  Vitamin E
n*9
1 0 0  - i 
80 -
PE Contraction 60  
(g tension per 0.1g tissue)
40  
20 
0
CONTROL Vitamin E (100pM ) 500pg /m l LDL/Vit. E
LDL
FIG. 7.8 - Effect of LDL (500|xg/ml) +/- 100piM vitamin E
maximum phenylephrine-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
Krebs Control 
Vitamin E (1 0 0 /jM) 
500(jg/ml LDL 
LDL/Vit. E
n=9
on
on
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No alteration in this LDL-mediated reduction of
response was observed on incubation in the presence 
of vitamin E.
Vitamin E alone had no significant effect on tissue 
responses to phenylephrine, when compared with 
appropriate controls.
1.5.2.2 Effect of LDL +/- Vitamin E on 
Carbacho 1-media ted Endothelium-dependent Relaxation
The effect of LDL +/- vitamin E on stimulated NO
release was investigated by examination of responses 
to the muscarinic agonist carbachol.
In the present study incubation of tissues with 
500)ig/ml LDL had no effect on carbachol
concentration-response curve sensitivity (Fig. 7.9).
On incubation of tissues with LDL, results did
however, suggest a reduction in maximum 
carbachol-induced relaxation (as seen previously in 
chapter 6)(Fig. 7.10).
Incubation in the presence of vitamin E appeared to 
attenuate this LDL-mediated reduction in maximum 
carbachol-induced relaxation (although this did not 
reach statistical significance, p=0.1376).
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RAT AORTA
Carbachol C oncentration-Response Curve
■ Krebs Control 
*  Vitamin E (100/uM) 
▼ 500/jg /m l LDL 
o LDL/Vit. E
20
40
Response (% relaxation)
n=860
80
100
10“#
Concentration (M)
FIG. 7.9 - Effect of LDL (500|xg/ml) +/- lOOfiM vitamin E
carbachol concentration-response curve in the rat aorta.
Effect of LDL on Carbachol Maximum Relaxation + / -  Vitamin E
n«*8
100
60
Response 
(X relaxation)
CONTROL Vitamin E (100pM) 500*jg/m l LDL/Vit. E
LDL
FIG. 7.10 - Effect of LDL (500fxg/ml) +/- 100|iM vitamin E 
maximum carbachol-induced relaxation in the rat aorta.
on
on
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Vitamin E alone had no significant effect on tissue 
responses to carbachol, when compared with 
appropriate controls.
7.5.2.3 Effect of LDL +/- Vitamin E on SNP-induced 
Relaxation
The effect of LDL +/- vitamin E on VSM sensitivity 
to exogenous NO was investigated by examination of 
responses to the NO donor compound SNP.
As previously, 500(ig/ml LDL had no significant 
effect on tissue sensitivity to SNP or maximum
relaxation achieved (Fig. 7.11).
Vitamin E alone had no significant effect on
SNP-mediated tissue responses.
7.5.2.4 Effect of LDL +/- Vitamin E on 
L-NAME-induced Contraction in the Rat Aorta
The effect of LDL + /- vitamin E on basal NO release
was investigated by examination of contractile
responses following exposure to the nitric oxide 
synthase inhibitor L-NAME.
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RAT AORTA
SNP C oncen tra tion-R esponse Curve
20 - ■ Krebs Control 
a 1OOpM VITAMIN E 
▼ 500 p g /m l LDL 
o LDL + VITAMIN E
4 0  -
Response { %  relaxation]
60 -
n=5
80 -
100
10-8
Concentration (M]
F I G .  7 . 1 1  - Effect of LDL (500fj,g/ml) + / - 100|iM vitamin E on 
SNP concentration-response curve in the rat aorta.
Effect of LDL on L-NAME Response + / -  Vitamin E
n=7
Contraction 125 -  
(As a X of 10-1M KCI response]
100 -
Vitamin E {10OpM) LD L/V it. ECONTROL 500 p g /m i
F I G .  7 . 1 2  - Effect of LDL (500p,g/ml) +/- 100)iM vitamin E on 
L-NAME-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
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Incubation of tissues with 500|ig/ml LDL caused a 
significant reduction in L-NAME-mediated contraction 
(Fig. 7.12).
Incubation in the presence of vitamin E had no 
significant effect on this LDL-mediated decrease in 
L-NAME response.
Vitamin E alone did not alter tissue responses to 
L-NAME, when compared with appropriate controls.
7.5.2.5 Effect of LDL +/- Vitamin E on Potassium 
Chloride Mediated Contraction in the Rat Aorta
The effect of LDL + /- vitamin E on 
receptor-independent contraction was investigated by 
examination of responses to potassium chloride 
(KCI).
As previously, 500|j,g/ml LDL treatment had no 
significant effect on tissue sensitivity to KCI 
(Fig. 7.13), or maximum contraction achieved (Fig. 
7.14) .
Vitamin E alone had no effect on KCl-induced tissue 
responses.
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RA T AO RTA
KCI C o n c e n tra tio n -R e s p o n s e  C urve
100
80
■ Krebs Control 
A Vitamin E (100|jM ) 
t 500pg/m l LDL 
o LDL/Vit. E
60
Response (X Max.)
40
n=9
20
0
0.10.01
Concentration (M)
F I G .  7 . 1 3  - Effect of LDL (500}ig/ml) +/- 100|iM vitamin E on 
potassium chloride concentration-response curve in the rat 
aorta.
Effect of LDL on KCI Maximum Contraction + / -  Vitamin E
n=9
5 0  I
4 0  -
Contraction 30  
(g tension per 0.1g tissue)
CONTROL Vitamin E (lOOpM] 500yg /m l LDL/Vit. E
FIG. 7.14 — Effect of LDL (500|ig/ml) +/- lOOjiM vitamin E on
maximum potassium chloride induced contraction in the rat
aorta.
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7.5.2.6 Effect of 5 Hour Incubation +/- Vitamin E on 
LDL Oxidation
Lipid peroxidation of native LDL was examined 
following 5 hour incubation in the presence and 
absence of vitamin E.
Incubation of LDL for 5 hours under standard 
incubation conditions (see 1.3.2), resulted in only 
a small increase in oxidative modification, which 
was not statistically significant (Fig. 7.15).
Results suggested that incubation in the presence of 
vitamin E reduced any oxidative modification of 
native LDL.
7 . 5 . 3  R E S U L T S  FR O M  S U P E R O X ID E  D IS M U T A S E  E X P E R IM E N T S
Effects of 500(ig/ml LDL and ox-LDL +/- 45 units SOD 
on vascular reactivity were examined in the rat 
aorta.
7.5.3.1 Effects of LDL and Ox-LDL +/- Superoxide 
Dismutase on Phenylephrine-induced Contraction in 
the Rat Aorta
Effects of LDL and ox-LDL +/- SOD on 
receptor-mediated contraction were investigated by
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examination of responses to the a, adrenoceptor 
agonist phenylephrine.
In the present study 500|ig/ml LDL and ox-LDL had no 
significant effect on tissue sensitivity to 
phenylephrine (Fig.s 7.16 & 7.17).
SOD alone had no significant effect on phenylephrine 
concentration-response curve sensitivity.
As previously, results suggested that ox-LDL 
treatment caused an increase in maximum 
phenylephrine induced contraction (Fig.s 7.18 &
7.20).
This increase in maximum phenylephrine-induced 
contraction was unaffected by incubation in the 
presence of SOD.
In the present study 500ng/ml LDL treatment had no 
effect on maximum phenylephrine-induced contraction 
(Fig.s 7.19 & 7.21) .
In both LDL and ox-LDL experiments incubation with 
SOD alone showed a tendency to reduce maximum
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RAT AO RTA
Phenylephrine C o n c e n tra tio n -R e s p o n s e  C urve
100
80
■ Krebs Control 
*  SOD (45  units) 
t 5 0 0 p g /m l o x -L D L  
o o x -L D L /S O D
60
Response (X Max.]
4 0
n=8
10“ 7 10~6 10"5 10~410~®
Concentration (M)
F I G .  7 . 1 6  - Effect of ox-LDL (500|ig/ml) +/- 45 units/ml SOD 
on phenylephrine concentration-response curve in the rat aorta.
RAT AO RTA
Phenylephrine C o n c e n tra tio n -R e s p o n s e  C urve
100 i
80  -
■  Krebs Control 
A SOD (45  units) 
▼ 5 0 0 (jg /m l LDL 
O LD L/SO D
60 -
Response (X Max.]
4 0  -
n=7
20 -
10"®
Concentration (M)
F I G .  7 . 1 7  - Effect of LDL (500|ig/ml) +/- 45 units/ml SOD on 
phenylephrine concentration-response curve in the rat aorta.
Note - % Max. = percentage of maximum phenylephrine response
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RAT AORTA
Phenylephrine Concentration-Response Curve
70 n
60 -
Response 50 - 
(g tension per 0.1g tissue) 
40 -
30 -
20 -
-A-" ±
10~# 10'6
■ Krebs Control 
A SOD (4-5 units)
▼ 500pg/ml ox-LDL  
O ox-LDL/SOD
n=8
Concentration (M)
FIG. 7.18 - Effect of ox-LDL (500p,g/ml) +/- 45 units/ml SOD 
on phenylephrine concentration-response curve in the rat aorta.
RAT AORTA
Phenylephrine Concentration-Response Curve
70 i
60 -
Response 50 - 
(g tension per 0.1 g tissue] 
40  -
30 -
20 -
-r '  -l
10 -
10 “ * 10'*
■ Krebs Control 
*  SOD (45 units) 
▼ 500 jjg /m l LDL 
o LDL/SOD
n=7
Concentration (M)
FIG. 7.19 - Effect of LDL (500(j,g/ml) +/- 45 units/ml SOD on
phenylephrine concentration-response curve in the rat aorta.
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E f fe c t  o f o x -L D L  on PE M axim um  C o n tra c tio n  + / -  S O D
PE Contraction 60  
(g tension per 0.1 g tissue)
CONTROL SOD (45 units) 500 p g /m l O X -LD L/S O D  
ox-LDL
FIG. 7.20 - Effect of ox-LDL (500|ig/ml) +/- 45 units/ml SOD 
on maximum phenylephrine-induced contraction in the rat aorta.
Effect of LDL on PE Maximum Contraction + / -  SOD
PE Contraction 60 
(g tension per 0.1g tissue)
CONTROL SOD (45 units) 500 p g /m l LDL/SOD
LDL
FIG. 7.21 - Effect of LDL (500)a,g/ml) +/- 45 units/ml SOD on
maximum phenylephrine-induced contraction in the rat aorta.
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phenylephrine-induced contraction when compared with 
appropriate controls.
7.5.3.2 Effects of LDL and Ox-LDL +/- Superoxide 
Dismutase on Carbacho1-media ted Endothelium 
Dependent Relaxation in the Rat Aorta
Effects of LDL and ox-LDL +/- SOD on stimulated NO 
release were investigated by examination of 
responses to the muscarinic agonist carbachol.
In the present study, incubation of tissues with 
500jrg/ml LDL or ox-LDL had no significant effect on 
carbachol concentration-response curve sensitivity 
(Fig.s 7.22 & 7.23).
As observed in chapter 6, results suggested that 
both LDL and ox-LDL (at a concentration of 500|^ g/ml) 
caused a reduction in maximum carbachol-induced 
relaxation (Fig.s 7.24 & 7.25).
This was unaffected by incubation in the presence of 
SOD.
SOD alone had no significant effect on tissue 
responses to carbachol, when compared with
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RAT AORTA
Carbachol C oncentration-Response Curve
■ Krebs Control 
A  SOD (45 units)
▼ 500 jjg /m l ox-LDL  
o ox-LD L/S O D
20 -
4 0  -
Response (% relaxation)
n=660 -
80 -
100
Concentration (M)
F I G .  7 . 2 2  - Effect of ox-LDL (500p.g/ml) +/- 45 units/ml SOD 
on carbachol concentration-response curve in the rat aorta.
RAT AORTA
C arbachol C o n cen tra tion -R esponse Curve
■ Krebs Control 
A SOD (45  units) 
▼ 5 0 0 p g /m l LDL 
o LDL/SO D
20 -
4 0  -
Response (X relaxation)
n = 560  -
80  -
100
Concentration (M)
F I G .  7 . 2 3  - Effect of LDL (500|ig/ml) +/- 45 units/ml SOD on
carbachol concentration-response curve in the rat aorta.
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E ffe c t  o f o x -L D L  on C arb ach o l M axim um  R elaxa tio n  + / -  SO D
n -6
1 0 0  -i
6 0
Response 
(X relaxation)
CO NTR OL SOD (4 5  units) 5 0 0 fjg /m l o x -L D L /S O D  
ox-LDL
FIG. 7.24 - Effect of ox-LDL (500|j.g/ml) +/- 45 units/ml SOD 
on maximum carbachol-induced relaxation in the rat aorta.
Effect of LDL on Carbachol Maximum Relaxation + / -  SOD
60
Response 
(X relaxation)
CO NTR OL 5 0 0 ^ g /m l LD L/S O D
FIG. 7.25 - Effect of LDL (500ng/ml) +/- 45 units/ml SOD on
maximum carbachol-induced relaxation in the rat aorta.
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appropriate controls (although maximum relaxation 
responses were variable).
7.5.3.3 Effects of LDL and Ox-LDL +/- Superoxide 
Dismutase on SNP-induced Relaxation in the Rat Aorta
Effects of LDL and ox-LDL +/- SOD on VSM sensitivity 
to exogenous NO was investigated by examination of 
responses to the NO donor compound SNP.
As previously, 500|4,g/ml ox-LDL caused a significant 
reduction in SNP concentration-response curve
sensitivity (Fig. 7.26).
This reduction in tissue sensitivity to SNP appeared 
greater in tissues incubated with both ox-LDL and 
SOD (although this did not reach statistical
significance).
A similar trend was observed on incubation with
500|ig/ml LDL; data suggesting a reduction in SNP 
concentration-response curve sensitivity
(p=0.6189) (Fig. 7.27) .
This appeared unaffected by incubation in the
presence of SOD.
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RAT AORTA
SNP C oncen tra tion -R esponse Curve
20 ■ Krebs Control 
*  SOD (4-5 units) 
t 500 (jg /m l ox-LD L  
o ox-LD L  + SOD
.T
40
* EC50Response (X relaxation)
60
n=6
60
100
10“ 9 10~8
Concentration (M)
F I G .  7 . 2 6  - Effect of ox-LDL (500}ig/ml) +/- 45 units/ml SOD 
on SNP concentration-response curve in the rat aorta.
* significant difference from control (p<0.05)
R A T AO RTA
SNP C o n c e n tra tio n -R e s p o n s e  C urve
20 - ■ Krebs Contro l 
a SOD (4 5  units) 
▼ 5 0 0 p g /m l LDL 
O LDL +  SOD
4 0  -
Response (% relaxation)
6 0  -
n=6
8 0  -
100
10-* 10-8
Concentration (M)
F I G .  7 . 2 7  - Effect of LDL (500|xg/ml) +/- 45 units/ml SOD on
SNP concentration-response curve in the rat aorta.
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SOD alone had no effect on tissue responses to SNP, 
when compared with appropriate controls.
7.5.3.4 Effects of LDL and Ox-LDL +/- Superoxide 
Dismutase on L-NAME-induced Contraction in the Rat 
Aorta
Effects of LDL and ox-LDL +/- SOD on basal NO 
release was investigated by examination of 
contractile responses following exposure to the 
nitric oxide synthase inhibitor L-NAME.
As in chapter 6, 500|ig/ml ox-LDL caused a
significant reduction in contraction following 
L-NAME exposure (Fig. 7.28).
LDL treatment showed a similar trend (Fig. 7.29) .
Incubation in the presence of SOD had no significant 
effect on this LDL/ox-LDL mediated reduction in 
L-NAME response.
SOD alone showed a tendency to decrease 
L-NAME-induced contraction however, this was minimal 
and did not reach statistical significance.
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E ffe c t o f o x -L D L  on L -N A M E  Response + / -  SOD
(1=6
150
Contraction 125 
(As a X of 10-1M KCI response)
100
CONTROL SOD (45 units] 500 fjg /m l o x -L D L /S O D
ox-LDL
FIG. 7.28 - Effect of ox-LDL (500|ig/ml) +/- 45 units/ml SOD 
on L-NAME-induced contraction in the rat aorta.
* significant difference from control (p<0.05)
Effect of LDL on L-NAME Response + / -  SOD
n -5
175 -i
150 -
Contraction 125 - 
(As a X of 10-1M KCI response)
100 -
CONTROL SOD (45 units] 500 p g /m l LDL/SO D
LDL
FIG. 7.29 - Effect of LDL (500jj.g/ml) +/- 45 units/ml SOD on
L-NAME-induced contraction in the rat aorta.
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7.5.3.5 Effects of LDL and Ox-LDL +/- Superoxide 
Dismutase on Potassium Chloride Mediated Contraction 
in the Rat Aorta
Effects of LDL and ox-LDL +/- SOD on 
receptor-independent contraction were investigated 
by examination of responses to potassium chloride 
(KCI).
As previously, LDL and ox-LDL treatment had no 
significant effect on tissue sensitivity to KCI 
(Fig.s 7.30 & 7.31).
In the present study, 500|ig/ml ox-LDL caused a 
significant increase in maximum KCl-induced 
contraction; a similar (although minimal) trend 
being observed following LDL treatment (Fig.s 7.32 & 
7.33) .
This was unaffected by incubation in the presence of 
SOD.
SOD alone had no effect on tissue responses to KCI, 
when compared with appropriate controls.
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RAT AORTA
KCI C o n c e n tra tio n -R e s p o n s e  C urve
100
80
■ Krebs Control 
A  SOD (45  units)
▼ 5 0 0 |ig /m l o x -L D L  
o o x -L D L /S O D
60
Response (% Max.]
4 0
20
0.10.01
Concentration (M)
F I G .  7 . 3 0  - Effect of ox-LDL (500(j.g/ml) +/- 45 units/ml SOD 
on potassium chloride concentration-response curve in the rat 
aorta.
RAT AO RTA
KCI C o n c e n tra tio n -R e s p o n s e  C urve
100  -I
80  -
■  Krebs Control 
A SOD (45  units) 
▼ 5 0 0 ^ g /m l LDL 
o LD L/SO D
60  -
Response (% Max.]
4 0  -
n=6
20 -
0.01 0.1
Concentration (M)
F I G .  7 . 3 1  - Effect of LDL (500fj.g/ml) +/- 45 units/ml SOD on
potassium chloride concentration-response curve in the rat
aorta.
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E ffe c t  o f o x -L D L  on K CI M axim um  C o n tra c tio n  + / -  S O D
n -7
Contraction 30  
(g tension per 0.1g tissue)
C O N TR O L SOD (4 5  units) 5 0 0 jjg /m l o x -L D L /S O D
ox-LDL
FIG. 7.32 - Effect of ox-LDL (500jxg/ml) +/- 45 units/ml SOD 
on maximum potassium chloride induced contraction in the rat 
aorta.
* significant difference from control (p<0.05)
Effect of LDL on KCI Maximum Contraction + / -  SOD
n -6
4 0  -
Contraction 3 0  - 
(g tension per 0.1 g tissue)
C O N TR O L SOD (4 5  units) 5 0 0 y g /m l LD L /S O D
LDL
FIG. 7.33 - Effect of LDL (500jxg/ml) +/- 45 units/ml SOD on
maximum potassium chloride induced contraction in the rat
aorta.
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7.6 DISCUSSION
The aim of the present study was to investigate 
possible mechanisms underlying LDL and ox-LDL 
effects on vascular reactivity in the rat aorta.
7.6.1 DEXAMETHASONE EXPERIMENTS
In chapter 6, LDL and ox-LDL were found to attenuate 
contractile responses to the NO synthase inhibitor 
L-NAME, suggesting a decrease in basal NO levels.
Induction of inducible NO synthase (iNOS) is 
however, known to occur readily in the rat aorta.
In the present study it was hoped to elucidate the 
relative contributions of iNOS and endothelial eNOS 
to L-NAME-mediated responses, and establish the 
effect of LDL and ox-LDL on their individual 
activity.
7.6.1.1 Substantiation of Basal NO Measurement
Removal of the endothelium in preincubation rings 
caused a significant reduction in L-NAME-induced 
contraction by greater than 70%, demonstrating that 
NO activity measured was mainly endothelium 
dependent (eNOS).
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Following a 5 hour incubation only a small induction 
of iNOS occurred, which did not reach statistical 
significance. This was blocked in the presence of 
dexamethasone.
These results therefore substantiate our previous 
assumption that L-NAME-induced responses were mainly 
representative of basal NO release from the 
endothelium.
Interestingly, on removal of the endothelium prior 
to incubation, induction of iNOS increased 
considerably (returning NO activity to endothelium 
intact levels), and could be specifically inhibited 
by dexamethasone.
Similar to this Moritoki et al., 19921'2, also found 
induction of NO synthesising mechanisms in the 
vascular smooth muscle over similar time periods. 
L-arginine induced relaxation was found to occur 
irrespective of whether the endothelium was present 
or absent. Detection of responses were possible 2 
hours after removal of the endothelium and the start 
of experimentation, and increased progressively to 
reach a maximum at 6 hours.
182
Other groups such as Adeagbo and Triggle, 1993, have 
also suggested that endothelial cell removal/damage 
triggers the induction of a smooth muscle NO 
synthase.
This upregulation of iNOS activity suggests a 
possible regulatory defense pathway, whereby 
endothelial damage and the resultant reduction of 
eNOS activity, triggers upregulation of iNOS 
activity in the vascular smooth muscle and 
restoration of NO to previous levels.
7.6.1.2 The Effect of LDL and Ox-LDL on iNOS and 
eNOS activity in the Rat Aorta
The effect of LDL and ox-LDL on iNOS and eNOS 
activity was investigated by examination of the 
effects of dexamethasone on L-NAME responses +/- LDL 
and ox-LDL.
Since dexamethasone specifically inhibits iNOS, 
comparisons were made between tissues incubated in 
dexamethasone only, and those incubated in 
dexamethasone and LDL/ox-LDL. Similar measurements 
for example, would suggest inhibition of iNOS only, 
whereas greater inhibition in dexamethasone and 
LDL/ox-LDL tissues would suggest inhibition of eNOS 
also.
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Results suggested that incubation with both LDL and 
dexamethasone reduced L-NAME-induced contraction to 
a similar degree as incubation with dexamethasone 
alone.
Ox-LDL treated tissues showed a similar pattern, 
with a trend towards lower responses when incubation 
included both ox-LDL and dexamethasone.
LDL and ox-LDL therefore appear to have their main 
effect on iNOS (although ox-LDL may also have a 
small effect on eNOS).
These results suggest that LDL and ox-LDL may help 
accelerate the atherosclerotic process by causing 
dysfunction in regulatory defense pathways, which 
would result in abnormally low pathophysiological 
levels of NO (see Fig. 7.34).
7.6.2 VITAMIN E EXPERIMENTS
The second aspect of the present study, was an 
examination of the effects of vitamin E on 
LDL-induced alterations of vascular reactivity. 
Vitamin E alone had no significant effect on 
vascular reactivity when compared with appropriate 
controls.
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Possible NO Regulatory Feedback Pathway and Site of 
LDL/Ox-LDL Action
ENDOTHELIAL DAMAGE
i
REDUCED LEVELS OF 
ENDOTHELIUM-DEPENDENT 
NO
SITE OF LDL/OX-LDL 
ACTION
UPREGULATION OF iNOS ACTIVITY IN THE 
VASCULAR SMOOTH MUSCLE
i
RESTORATION OF NO LEVELS
FIG. 7.34 - Possible NO regulatory feedback pathway and site 
of action of LDL and ox-LDL.
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Incubation in the presence of vitamin E had few 
effects on LDL-induced alterations of vascular
reactivity.
Results suggested that only LDL-mediated attenuation 
of maximum carbachol-induced relaxation may be 
reduced in the presence of vitamin E.
On measurement of lipid peroxidation levels 
following incubation, vitamin E showed a tendancy to 
reduce any oxidative modification of native LDL. 
However, using the present techniques measurement of 
minimal oxidation and elucidation of possible
vitamin E effects on this partial oxidation process 
was not possible.
Various explanations for vitamin E's lack of effect 
may be proposed, including the concentration of 
vitamin E used.
Alternatively, combination of vitamin E into the LDL 
particle (as seen in vivo) may be required before
vitamin E can exert a protective effect.
These results highlight the controversy surrounding 
the exact beneficial effects, and mechanisms of
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action, of antioxidants in the prevention of 
atherosclerotic disease.
It can therefore be concluded from the present study 
that 100(oM vitamin E did not affect any of the 
alterations in vascular reactivity observed 
following exposure to LDL. Vitamin E did however,
show a tendancy to alleviate LDL specific
attenuation of carbachol-stimulated NO release.
Mechanisms of action of LDL and ox-LDL could not be 
elucidated from this part of the study.
7.6.3 SUPEROXIDE DISMUTASE EXPERIMENTS
The final part of the present study examined the
effects of SOD on LDL and ox-LDL induced alterations 
of vascular reactivity.
SOD alone, showed a tendency to reduce maximum
phenylephrine-induced contraction when compared with 
appropriate controls.
Similarly, Mian and Martin, 1995, found that SOD 
(1-300 u ml-1) induced a concentration-dependent 
relaxation of phenylephrine-induced tone in 
endothelium intact rat aortic ring preparations.
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These results support suggestions that free
radicals, in particular superoxide, are natural
regulators of NO. SOD inactivation of superoxide 
anion would therefore reduce NO neutralisation,
leading to increased NO levels and greater
suppression of contractile responses.
Apart from this tendency to reduce maximum
receptor-dependent contraction SOD alone had no 
other effect on vascular responses studied.
Incubation in the presence of SOD had few effects on
LDL and ox-LDL induced alterations of vascular
reactivity.
Interestingly, results suggested that ox-LDL-induced 
reduction in tissue sensitivity to SNP was enhanced 
to a small extent, in tissues incubated in the 
presence of SOD.
This substantiates results of Dowell, 1993, who 
found accentuated impairment of carbachol-stimulated 
relaxation, following incubation with a xanthine 
oxidase/hypoxanthine free radical/reactive oxygen 
species generating system in the presence of SOD.
188
SOD is known to rapidly convert superoxide anion to 
hydrogen peroxide, which may then be scavenged by 
catalase.
In the present study, incubation with SOD may have 
caused accumulation of hydrogen peroxide (which is 
itself a free radical) in the absence of sufficient 
catalase activity.
Groups such as Link and Riley, 1988, have suggested 
that hydrogen peroxide is the major cytotoxic
product formed by the xanthine/xanthine oxidase 
system, and not the superoxide anion as first
thought.
Indeed Dowell, 1993, concluded that hydrogen
peroxide was the primary reactive oxygen species 
responsible for impairment of carbachol-induced 
endothelium-dependent relaxation in aortic rings 
(although superoxide may also have a detrimental 
effect).
Additionally, reaction of superoxide anion and 
hydrogen peroxide leads to the formation of highly
reactive hydroxyl radicals which are known to set 
off toxic free radical chain reactions (Sinatra and 
DeMarco, 1995).
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Of future interest will be the study of ox-LDL 
effects in the presence of SOD and catalase, but 
also catalase alone, to further elucidate the 
importance of superoxide anion and hydrogen
peroxide radicals in this system.
Incubation with SOD had no other effects on LDL and 
ox-LDL induced alterations of vascular reactivity.
Reasons for this may be the inability of SOD to 
enter the cell. As a result further studies using 
free radical scavengers such as tiron, which are 
capable of acting both intra and extracellularly 
would be of considerable interest.
Alternatively, dysfunctional effects may be due to 
any of the other numerous free radicals thought to 
be formed including hydrogen peroxide, peroxynitrite 
and hydroxyl species.
It can therefore be concluded from the present study 
that 45 units/ml SOD showed a tendency to enhance 
ox-LDL-induced alterations in tissue sensitivity to 
SNP, but had no other effect on LDL and ox-LDL 
mediated changes in vascular reactivity.
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In the present study there was only weak evidence to 
suggest that induction of NO dysfunction by low 
density lipoproteins may be partially due to free 
radical neutralisation of the NO molecule. 
Incubation with SOD alone, had few effects on 
LDL/ox-LDL mediated alterations of vascular 
reactivity, and further studies (such as those 
suggested above) will be required to substantiate 
(or disprove) this theory.
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8
GENERAL DISCUSSION 
(AND FUTURE DIRECTIONS)
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8.1 DISCUSSION
Hypercholesterolemia is an important risk factor in 
the development and progression of atherosclerotic 
disease.
The initial aims of this thesis were to characterise 
effects of LDL and ox-LDL on vascular reactivity in 
vitro, and to investigate possible mechanisms of 
action.
8.1.1 CHOLESTEROL UPTAKE
Various groups have suggested that increased 
cholesterol content within the cell membrane may be 
an initiator of proatherogenic changes at the level 
of membrane physicochemical structure and calcium 
influx (Scott-Burden et al., 1989; Yeagle, 1989;
Bialecki et al., 1991; Figueiredo et al., 1991; 
Thorin et al., 1995).
VSM cells are one of two cell types predominant in 
the atherosclerotic lesion, however mechanisms by 
which increased cholesterol accumulation may occur 
in these cells are controversial.
VSM cholesterol uptake was therefore investigated by 
comparison of the effects of LDL and ox-LDL on free
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and total membrane cholesterol levels in cultured
cells.
On exposure of VSM cells to LDL and ox-LDL, similar 
small increases in free and total membrane 
cholesterol content were observed, supporting
theories that VSM cells may not normally express 
acetyl LDL receptors, but can accumulate cholesterol 
via a receptor-independent mechanism.
Further studies could have been carried out to 
investigate the consequences of increases in
cholesterol content on biochemical pathways,
however, it would have been difficult to relate such 
findings in cell culture directly to changes in
vascular function. Further investigations were 
therefore carried out in isolated ring preparations.
8.1.2 LDL AND OX-LDL EFFECTS
Several previous studies examining effects of LDL 
and ox-LDL on vascular reactivity were flawed due to 
the use of exceptionally high concentrations of
ox-LDL (Jacobs et al., 1990; Galle et al., 1991),
which is thought to represent only a small 
proportion of LDL in the body (Yla-Herttuala et al., 
1989). Other studies measured responses in the 
presence of the effector lipoproteins (Jacobs et
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al., 1990; Simon et al., 1990.}, therefore excluding 
the separation of lipoprotein-induced acute agonist 
responses known to occur, and longer term effects 
leading to vascular dysfunction (Simon et al., 1990; 
Murohara et al., 1994).
In the present study, effects on vascular reactivity 
were characterised in vitro in the rat aorta 
following 5 hour incubation with, and removal of, 
low and more realistic physiological concentrations 
of LDL and ox-LDL respectively. Concentrations of
LDL and ox-LDL used equated to 2 0ng/ml (2mg/dl),
lOO^g/ml (lOmg/dl), and 500|ig/ml (50mg/dl) (ie. a
person with cholesterol levels of 160-180mg/dl 
(4.2-4.7mmol/l) total cholesterol, will have 
approximately 104-117mg/dl plasma LDL (Feher and 
Richmond, 1991)).
Thus concentrations of LDL and ox-LDL used were 
physiological and pathophysiological rather than 
pharmacological.
On examination of NO-dependent responses LDL and 
ox-LDL exposure caused impairment of
carbachol-induced endothelium dependent relaxation, 
and attenuation of L-NAME mediated contraction.
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Ox-LDL (but not LDL) also impaired SNP-induced
endothelium independent relaxation.
On investigation of contractile responses LDL and 
ox-LDL exposure augmented phenylephrine-induced
contraction, and showed a tendancy to increase 
maximum contractions due to potassium chloride.
LDL and ox-LDL were therefore found to effect
numerous aspects of vascular reactivity and have a 
wide ranging effect on vascular function (effects 
included alteration of both endothelium and VSM 
dependent pathways; and modification of contractile, 
as well as relaxant responses).
8.1.3 MECHANISMS OF ACTION
Several possible mechanisms underlying LDL and
ox-LDL effects on vascular reactivity were
investigated.
8.1.3.1 NOS Inhibitlon
Studies using dexamethasone to inhibit iNOS, 
indicated that LDL and ox-LDL could cause
dysfunction of the NO pathway by inhibiting the 
inducible form of NOS (although ox-LDL may also have 
a small effect on eNOS).
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Interestingly during this part of the study, removal 
or damage of the endothelium was found to 
considerably increase iNOS induction (returning NO 
activity to endothelium intact levels).
Results therefore point to a novel hypothesis 
whereby LDL and ox-LDL may accelerate the 
atherosclerotic process by causing dysfunction of 
regulatory defense pathways, which would result in 
abnormally low pathophysiological levels of NO.
8.1.3.2 Free Radical Neutralisation
Free radical neutralisation of the NO molecule was 
also investigated as a possible mechanism of LDL and 
ox-LDL induced vascular dysfunction.
Effects of SOD on LDL and ox-LDL induced alterations 
of vascular reactivity were examined, due to 
numerous suggestions that the damaging free radical 
species involved is the superoxide anion (Ohara et 
al., 1993; Araujo et al., 1995; Pritchard et al., 
1995).
Incubation in the presence of SOD did not 
significantly alter LDL and ox-LDL mediated effects 
on vascular reactivity, and results suggested that
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SOD may even enhance ox-LDL-induced reduction of 
tissue sensitivity to SNP.
Interestingly SOD alone, showed a tendency to reduce 
maximum phenylephrine-induced contraction when 
compared with appropriate controls, suggesting a 
constant basal release of superoxide in the 
vasculature.
In the present study, there was therefore at the 
most only weak evidence to suggest that LDL and 
ox-LDL mediated dysfunction may be partially due to 
free radical neutralisation. However such results 
may simply indicate that the damaging reactive
species involved is not in fact superoxide (a theory 
already suggested by numerous groups).
8.1.4 ADDITIONAL INVESTIGATIONS
8.1.4.1 Risk Factor Interactions
Hypertension and hypercholesterolemia were also 
examined as coexisting and interactive risk factors 
using a multiple risk model.
Mechanisms by which hypertension contributes to
atherogenesis have not been established, however a 
synergy between the two risk factors has been
suggested (Walton, 1975; Feher and Richmond, 1991) .
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Results suggested that incubation of SHRSP VSM cells 
with LDL and ox-LDL produced greater increases in 
free cholesterol content (on comparison with their 
WKY normotensive reference strain), and that this 
was marginally greater in ox-LDL treated cells.
These results indicate a possible interactive 
mechanism between hypertension and
hypercholesterolemia, whereby hypertension could 
accelerate atherosclerotic progression by increasing 
cholesterol uptake by cells.
Preliminary examination of the effects of cell 
stretch on ox-LDL-induced cholesterol uptake, using 
a novel cell stretch apparatus, were inconclusive, 
however demonstrated a potential model for future 
investigations of hemodynamic forces on cellular 
function.
8.1.4.2 Antioxidant Effects
Another additional aim of this thesis was to examine 
the effects, and possible benefits of antioxidants, 
in the prevention of LDL and ox-LDL induced vascular 
dysfunction.
Vitamin E has recently been suggested to have 
additional non-antioxidant anti-atherogenic effects,
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including an additional role in cholesterol flux 
alteration of the cell membrane (Ozer et al., 1993; 
Boscoboinik et al., 1994, 1995; Thorin et al.,
1995).
As a result the effects of the antioxidants vitamin 
E and NAC on LDL and ox-LDL mediated cholesterol 
uptake were examined in cultured WKY and SHRSP VSM 
cells.
In the presence of vitamin E both LDL and ox-LDL 
mediated effects were attenuated in both cell types. 
Interestingly, vitamin E also reduced basal free 
membrane cholesterol levels in a concentration 
dependent manner.
Results indicate that the main observed effects of 
vitamin E are not a result of its antioxidant 
properties, and suggest that other mechanisms of 
action are involved.
NAC produced only a small attenuation of LDL and 
ox-LDL mediated effects on cholesterol uptake in WKY 
and SHRSP VSM cells, and did not alter basal free 
cholesterol content of cells.
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NAC's effects were also not attributable to its 
antioxidant properties alone, however results showed 
that NAC did not share all vitamin E's mechanisms of 
action.
Numerous groups have also suggested that observed 
LDL mediated effects are mainly attributable to LDL 
which has been oxidatively modified.
As a result the effects of vitamin E on LDL-induced 
alterations of vascular reactivity were examined in 
isolated aortic ring preparations from rat aorta. 
Vitamin E was found to have no significant effect on 
LDL-induced alterations of vascular reactivity
(although results suggested that LDL-mediated 
attenuation of maximum carbachol induced relaxation 
may be reduced to a small extent in the presence of 
vitamin E).
Such results highlight the controversy already
surrounding the actual actions and effects of
antioxidants in atherosclerotic protection.
8.2 CONCLUSIONS
In conclusion, the work presented in this thesis has 
provided novel information on the effects of LDL
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cholesterol on vascular function, and the possible 
mechanisms of action involved.
LDL and ox-LDL were demonstrated to have wide
ranging effects on vascular function, which could be 
mainly attributed to dysfunction of the NO pathway 
(at both basal and stimulated levels).
Studies involving investigation of possible 
mechanisms of action indicate that LDL and ox-LDL 
induced vascular effects probably occur via a 
complex multidysfunctional mechanism, resulting from 
a combination of interference at several mechanistic 
sites.
Hypertension and hypercholesterolemia were 
investigated as coexisting and interactive risk
factors and a possible site of interaction
demonstrated.
Finally, additional non-antioxidant properties of 
the antioxidants vitamin E (and to a lesser extent
NAC), were elucidated.
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8.3 FUTURE WORK
The potential for future work resulting from this 
thesis are wide ranging, and many have been 
discussed previously in the individual chapters.
Increased knowledge and understanding of the 
mechanisms of action of LDL cholesterol, and the 
individual importance of the various dysfunctional 
sites will be of value in the future to allow 
possible targeting for preventative medicine, and 
reduction of cholesterol enhanced atherosclerotic 
damage.
Such knowledge will also be invaluable in improving 
understanding of the physiology of the vascular 
system.
Increased investigation of risk factor interactions, 
with particular reference to hypertension and 
hypercholesterolemia, will also be of much interest.
Free radical involvement has been suggested in the 
pathobiology of both essential hypertension and 
hypercholesterolemic enhancement of atherosclerotic 
disease (Auch-Schwelk et al., 1989; Kumar and Das, 
1993; Ohara et al., 1993; Araujo et al., 1995;
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Keaney and Vita, 1995), suggesting another potential 
site of interaction.
Further examination of interactions between 
hypertension and hypercholesterolemia could be 
carried out by comparison of LDL and ox-LDL mediated 
effects in isolated aortic ring preparations from 
WKY and SHRSP rats.
Alternatively, establishment of the effects of 
perfusion pressure on LDL and ox-LDL induced 
vascular alterations in isolated arterial 
preparations, would also be of great interest.
Finally, examination of LDL and ox-LDL effects on 
human vascular function will be of prime importance 
in the future.
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APPENDIX 
I Materials 
CHEMICALS
GIBCO/LIFE TECHNOLOGIES LTD
All cell culture chemicals, buffers and reagents 
SIGMA
Butylated Hydroxytoluene (BHT) B137 8
Carbachol C4382
Collagenase Type II C6885
Cholesterol C8667
Dexamethasone D1756
Elastase Type IV E0258
17(3 Estradiol E8875
Folin & Ciocalteu's Phenol Reagent F9252
Fibronectin FI 141
Indomethacin 17378
Lauryl Sulfate L4509
L-NAME N5751
NALC A72 50
Phenylephrine P6126
Soybean Trypsin Inhibitor (SBTI) T6522
Superoxide Dismutase (SOD) S2515
2-Thiobarbituric Acid (TBA) T5500
1,1,3,3 - Tetramethoxypropane T1642
Vitamin E T3634
Chemicals used in cholesterol and protein assays
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Sodium nitroprusside and cocaine hydrochloride were 
obtained from the Western Infirmary (General 
Stores). All other chemicals were obtained from BDH.
2 LDL/OX-LDL Preparation Solutions 
SOLUTIONS
1. Density Solution - 1.006g/ml 
0.195M NaCl
11.4g NaCl + O.lg EDTA-Na2 + 500mls dH20
2. Density Solution - 1.182g/ml 
0.195M NaCl / 2.44M NaBr
24.98g NaBr + lOOmls 1.006g/ml density solution
3. Density Solution - 1.019g/ml
8mls 1.182g/ml density solution + lOOmls NaCl/Saline
4. Density Solution - 1.063g/ml 
1.006g/ml : 1.182g/ml
2 : 1 Ratio
5. Density Solution - 1.478g/ml
0.195M NaCl / 7 . 65M NaBr
78.32g NaBr + lOOmls 1.006g/ml density solution
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6. Density Solution - 1.21g/ml
1.063g/ml : 1.478g/ml
2 : 1 Ratio
7. Phosphate Buffer / Stock Dialysis Buffer 
i/ NaCl / Saline ie. 8.7 6g + 11 dH20
ii/ Na2HP04 (Anhyd.) ie. 10.65g + 750mls NaCl/Saline
iii/ NaH2P042H20 ie. 3. 9g + 250mls NaCl/Saline
iv/ Adjust pH of Na2HP04(ii) to 7.4 with NaH2P042H20
(iii)
v/ Dilute 1/10 before dialysis
8. Copper Chloride Solution - make fresh 
4|xM
i/ 0 . 00269g + lOOmls dH20 = 200|jM 
ii/ Add 20|iil/ml LDL solution = 4|UM CuCl2
3 Preparation of VSM cells - Digest Mix
Digest mix was prepared as follows
i/ 5mgs elastase type IV was dissolved in 2ml
serum free DMEM, and lOOjils of soya bean
trypsin inhibitor solution (ie.lOmgs SBTI + 1ml 
serum free DMEM) added
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ii/ 1ml of Collagenase type II solution (ie.25mgs 
COLL + 1ml serum free DMEM) was then added and 
the solution gently mixed by swirling.
iii/ The solution was made up to a final volume of 
20mls, mixed, and filtered through a 0.22 
millipore filter.
4 Vascular Smooth Muscle Growth Medium
CONTENTS CONCENTRATION QUANTITY
DMEM 500mls
Foetal Calf Serum 10% (V:V) 50mls
Horse Serum 10% (V:V) 50mls
Gentamicin (lOmg/ml) 100|ig/ml 5mls
Glutamine (200mM) 2mM 5mls
Penicillin/Streptomycin 100IU/100jj,g/ml 5mls
(10, 000IU/10, 000|ig/ml)
Fungizone (250|ag/ml) 5p,g/ml lOmls
5 Cholesterol Assay Stock Solutions -store at 4°C
1. Na Cholate 
FW= 430.6 
20mM
eg. 8 6.12mg in lOOmls dH20
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2. Triton X 100 
0.5%
eg. 0.5ml in lOOmls dH20
3. Pi Potassium Hydrogen Phosphate( K?HPOd buffer ) - 
pH7.4
FW= 174.18 
0.1M
eg. 1.7418g in lOOmls dH20
4. Ethanol 
95%
eg. 475mls absolute ETOH + 25mls dH20
5. Cholesterol standard
0. 4mg/ml
eg. 20mg in 50mls 95% ETOH
Note - Sonicate for 15 minutes to insure proper 
dissolution
Make the following up in 0.1M K2HP04 buffer (pH7.4):-
6. Cholesterol esterase
0. lu/ml
eg. 5 units in 1ml = 5u/ml stock solution
200pils stock solution in lOmls = 0. lu/ml
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7. Cholesterol oxidase 
lu/ml
eg. 100 units in 1ml = lOOu/ml stock solution 
lOOmls stock solution in lOmls = lu/ml
8. Horseradish peroxidase 
lOu/ml
eg. 5000 units in lOmls = 500u/ml stock solution 
200|uls stock solution in lOmls = lOu/ml
9. p-hydroxyphenylacetic acid 
4 mg/ml
eg. 40mg in 10 mis
6 Protein Assay Solutions
1. Bovine Serum Albumin
To be made up 24 hours prior to assay
25mg BSA in 50ml 1M Sodium Hydroxide = 500p,g/ml 
stock solution 
Store at 4°C
Make up as required:-
2. Solution A
2g Na2C03 in lOOmls 0. 1M NaOH
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3. Solution B
lOOmg CuS04 + 200mg NaK Tartrate in 20mls dH20 
NOTE - Must dissolve CuS04 completely in approx. 1/2 
volume before adding NaK Tartrate and making up to 
end volume
4. Sodium Copper Tartrate Solution 
lOOmls solution A + 20mls Solution B
5. Folins Solution
4mls Folins reagent + 4mls dH20 ie.l:l dilution
7 Krebs Bicarbonate Buffer
CONTENTS
pH 7.4
CONCENTRATION fmM ) QUANTITY (e/511
Ca EDTA 
Glucose 
KC1
KH2P04
MgS04
NaCl
NaHCO,
0.05
11.1
4.7
1.2
1.2
118.3
25.0
0.0935
10.0
1.75
0.80
1.50 
34.55
10.50
CaCl, 2.5 12.5ml (1M)
17(3 Estradiol 0.01 0.0135
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Indomethacin 0.01 0.0180
Cocaine HC1 0.01 5ml(102M)
NOTE - 17P estradiol and indomethacin dissolved in 
lml DMSO prior to addition.
8 TBA Assay Reagents
1. 8.1% Sodium Dodecyl Sulphate (SDS) 
i/ 8.lg SDS + 100ml dH20
ii/ Dilute 1:3 with dH20 prior to use
2. 20% Acetic Acid
i/ 20ml pure acetic acid + 80ml dH20
ii/ pH adjust to 3.5 and make up to 100ml
3. 0.8% TBA Reagent
i/ 0.8g TBA + 50ml dH20
ii/ Add 50ml pure acetic acid
iii/ Dilute with 20% acetic acid 1:1
NOTE - Must be prepared daily. Protect from light.
4. Standard Solution
i/ 0.1642g MDA + 100ml dH20 = 10_2M 
ii/ Dilute to 10_5M
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